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1. Introduction 
One of the most dreaded side effects of a number of compounds in development and 
clinically used drugs is their pro-arrhythmic potential causing malignant ventricular 
arrhythmias including Torsades de Pointes (TdP) polymorphic ventricular tachycardia that 
can lead to sudden cardiac death. Predicting TdP in clinical settings is a very difficult task 
since the incidence of drug induced TdP is very low (1:100000). A significant portion of 
compounds are withdrawn due to their prolonging effect on repolarization and incidence of 
TdP during the development process. 
Drug-induced arrhythmias were generally considered as the consequence of impairment 
of the cardiac repolarization process that usually leads to QTc prolongation on the ECG. 
However, recent studies suggest that QTc prolongation is not necessarily associated with the 
occurrence of TdP and in these cases ventricular repolarization reserve may be reduced 
without significant changes in the duration of cardiac repolarization. A number of studies 
suggest that increased short-term variability of QT interval, a novel ECG parameter correlates 
better with decreased repolarization reserve and the incidence of malignant ventricular 
arrhythmias. 
Another possible predictor of ventricular arrhythmias is the impaired frequency 
adaptation of the QT interval to sudden heart rate changes. Slow QT interval rate adaptation 
has been related to increased risk of development of afterdepolarizations and triggered 
activity, which could eventually result in TdP in a vulnerable substrate (Burashnikov et al. 
1998). 
 
1.1 The concept of repolarization reserve 
The term “repolarization reserve” was coined by Dan Roden (Roden, 1998) and 
according to this concept, the complexity of cardiac repolarization process includes some 
redundancy. As a consequence, the loss of one component of repolarizing currents (e.g. IKr) 
does not lead to repolarization abnormalities (i.e. marked QT prolongation) because the other 
components can compensate for the lost function of the impaired current. On the other hand, 
in the case of reduced repolarization reserve, even mild inhibition of another repolarizing 
current can result in excessive repolarization prolongation and serious ventricular 
arrhythmias. Therefore, decreased repolarization reserve makes the myocardium more 
sensitive to pro-arrhythmic agents without marked QTc prolongation. Consequently, adequate 
pro-arrhythmia models with impaired repolarization reserve (mimicking, at least in part, 
pathological clinical settings) are needed to reliably assess the possible TdP provoking side 
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effect of pharmaceutical compounds thus contributing to improved prevention of drug-
induced sudden cardiac death in humans. 
 
1.2 Cardiac ionic currents and their possible role in repolarization reserve and 
repolarization adaptation 
The action potential of cardiac myocytes is the result of the highly regulated and 
coordinated function of different transmembrane ionic channels and transporters. The trans-
sarcolemmal ionic movement through the pore forming units of transmembrane ion channels 
is driven by the transmembrane electrochemical gradient. These ion channels can be classified 
regarding to the mechanisms that regulate their opening: there are voltage gated (e.g inward 
sodium current (INa)) and ligand gated ion channels (e.g. acetylcholine-activated potassium 
current (IK,Ach)). These channels represent complicated structures consisting of 
transmembrane proteins with different subunits: the pore forming alpha and channel function 
modulating beta and/or gamma subunits that regulate the activation and inactivation 
properties of these channels. It is well known that there are significant apicobasal, transmural 
as well as chamber specific differences in the expression of these channels and the densities of 
ionic currents they carry. 
 
1.2.1 Inward sodium current (INa) 
The rapid depolarization phase (phase 0) of the action potential and consequently the 
fast conduction are attributed to the fast inward rectifier sodium current (INa). The channel 
possesses double gated properties regulated by the activation and inactivation gates. The 
sodium channels are closed at resting membrane potential during diastole due to the closed 
state of the activation gate and rapidly open (τ < 0.5 ms) on membrane depolarization that are 
more positive than  –60 mV while the inactivation gate is slightly slower closing (τ ̴ 0.5-5 
ms). Consequently, both gates are open for a short time (1 – 2 ms) and sodium ions flow into 
the cell driven by the electrochemical gradient resulting in rapid depolarization of the cell 
(phase 0 depolarization). However, at positive membrane potentials, the inactivation gate 
closes and remains closed during repolarization until the membrane potential returns to 
sufficiently negative values (inactive state). After the action potential when the membrane 
potential returns to the appropriate negative value, the activation gate closes (deactivation) 
and the inactivation gate opens again (τ ̴ 3 -25 ms) so the channel returns to its resting 
conformation during diastole (Antoni et al, 1988; Follmer et al, 1987; Fozzard et al, 1985; 
Varró et al, 1992; Whalley et al, 1995). In addition, a small fraction of the sodium current 
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inactivates slowly during the plateau phase (window INa), and this current is relatively potent 
in Purkinje fibers (Attwell et al, 1979; Carmeliet, 1987). This persistent sodium current 
functionally opposes repolarizing potassium currents and delays repolarization. In some 
clinical pathological settings (e.g. long QT syndrome 3, heart failure) this current is 
augmented resulting in decreased repolarization reserve and prolongation of repolarization 
leading to malignant ventricular arrhythmias (Schwartz et al, 1995). 
 
1.2.2 L- type inward calcium current (ICa,L) 
The operation of the L-type inward calcium current is similar to that of INa, namely it 
possesses activation and inactivation gating mechanisms, the channels could be in activated, 
inactivated and resting states according to the cardiac cycle (Hirano et al, 1989; Isenberg et al, 
1982; January et al, 1989; Mitra et al, 1986; Varró et al, 1992; Whalley et al, 1995). The 
calcium current, like INa, exhibits both slowly inactivating and window components. The 
inactivation of the L-type calcium channels are dependent on intracellular calcium 
concentration ([Ca2+]i): increased [Ca2+]i accelerates the inactivation of the ICa,L. (Ca 
dependent inactivation). 
 
Consequently, the ICa,L are dynamically regulated by the Ca released 
from the sarcoplasmic reticulum during the cardiac cycle. Since [Ca2+]i changes dynamically 
during the cardiac cycle and it is regulated by many other factors (eg. protein kinase A, 
protein kinase C, phospholamban, ryanodine receptor Ca ATPase, calmodulin) (Bers, 2001), 
the exact role of the ICa,L in repolarization and repolarization reserve is difficult to establish. 
Due to the relatively slow inactivation of calcium channels, ICa,L plays a very important role in 
the maintenance of the plateau phase and has a key role in cardiac contraction. In case ICa,L is 
augmented, the plateau voltage is shifted to more positive values that may result in enhanced 
activation of outward potassium currents that may shorten repolarization. In several types of 
cardiac cells where INa is not present (sinoatrial node, atrioventricular node) or in seriously 
damaged cardiac tissue, the L- type calcium current can be responsible for the depolarization 
and conduction (slow type action potential). An important role is attributed to ICa,L in the 
frequency adaptation of the action potential duration and QT interval. The ICa,L block is 
associated with slower APD adaptation to heart rate changes that may lead to cardiac 
arrhythmias. 
 
1.2.3 Rapid delayed rectifier outward potassium current (IKr) 
IKr, that flows through HERG, MIRP and MinK protein constituted channels (Abbott et 
al, 1999), activates rapidly during depolarization (Gintant, 1996) at membrane potentials more 
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positive than -30 mV (τ  ̴40 ms). In contrast with INa and ICa,L, the operation of the channel is 
regulated by only one gating mechanism, the opening and closing of the activation gate. The 
opening of the gate is defined as activation and the closing of the gate, as opposed to the 
double gating mechanism, is called deactivation and not inactivation. The depolarization 
dependent activation of IKr channels are preceded by deactivation (Spector et al, 1996), 
consequently, the channels are largely closed during the plateau phase and open again when 
membrane potential decreases to around 0 mV and then slowly deactivate at negative 
membrane potential values. Its special gating properties, namely the fast deactivation and 
recovery from deactivation, render the channels an apparent inward rectifier and play an 
important role in the third phase of repolarization. The magnitude of the IKr current is under 
direct regulation of the extracellular potassium concentration [K+]o. Contrary to that might be 
expected from the Nernst and Goldman-Hodgkin-Katz equation, the IKr current increases with 
higher [K+]o while reduced [K+]o decreases the IKr current (Sanguinetti and Jurkiewicz, 1992; 
Yang et al, 1997). It has been found recently that the reduction of [K+]o promotes the 
internalization and degradation of the HERG channels in rabbit heart and in human cell lines 
resulting in prolonged repolarization and decreased repolarization reserve (Guo et al., 2009). 
These mechanisms may play an important role in the development of malignant arrhythmias 
following electrolyte disturbances. IKr may contribute to repolarization lengthening when 
repolarization is already prolonged (Virág et al., 2009) with a positive feedback mechanism. 
In the case of longer action potential duration (e.g in bradycardia), there is less IKr current at 
isochronal point of the time course of action potential contributing to further prolongation of 
repolarization. Because of these properties of the IKr current, repolarization becomes more 
vulnerable when depolarizing factors are augmented due to LQT3, or other repolarizing 
factors are reduced (e.g. LQT1). In this setting, a partial decrease of IKr may result in critical 
elongation of APD leading to early afterdepolarization (EAD) and TdP ventricular 
arrhythmia. The major part of APD prolonging antiarrhythmic and non-cardiac drugs exert 
their effect by inhibition of IKr current (Roden and Viswanathan, 2005). A significant 
inhibition of IKr leads to substantial APD prolongation (Varró et al, 2000; Lengyel et al, 2001; 
Jost et al, 2005). When inhibition is partial, the IKr reduction does not necessarily manifest in 
significant repolarization lengthening due to the compensatory function of other outward 
currents. However, in the presence of further APD prolonging factors such as bradycardia, 
excessive APD prolongation may develop. The torsadogenic effect of weak IKr inhibiting non-
cardiac drugs that do not markedly prolong the QT interval could be explained by this 
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phenomenon. As a result, IKr is one of the most important currents contributing to 
repolarization reserve (Varró and Baczkó, 2011).  
 
1.2.4 Slow delayed rectifier outward potassium current (IKs) 
The channel proteins of the slow component of the delayed rectifier potassium current 
constitute KvLQT1 alpha subunits and Mink and MIRP beta subunits. The IKs activates 
slowly during the plateau phase (τ ̴ 500-1000 ms) and deactivates relatively rapidly at 
negative membrane potentials (τ̴ ̴ 100-200 ms) (Jost et al, 2007; Virág et al, 2001). As an 
important consequence of the slow activation kinetics and small amplitude between 0 and +20 
mV, the contribution of IKs to repolarization is not considerable in normal circumstances, at 
physiological heart rate and action potential duration (Varró et al, 2000; Jost et al, 2005). 
However, when action potential duration is lengthened or sympathetic tone is increased, IKs is 
activated and plays an important role in the shortening of APD and in preventing extreme 
APD prolongation. The IKs current activates at positive membrane potential values, thus in the 
case of APD prolongation when the plateau phase is shifted to more positive values, more IKs 
can be activated protecting the cell from the further repolarization lengthening. 
Pharmacological block of IKs inhibits this feedback mechanism increasing the risk of 
arrhythmia. The activation of the IKs also increases after sympathetic stimuli (Volders et al, 
2003; Yazawa and Kameyama, 1990; Walsh and Kass, 1991), moreover, amplification of ICa,L 
under sympathetic tone shifts the plateau toward more positive membrane potential values 
resulting in further IKs activation and consequent APD shortening (Volders et al, 2003). Thus, 
inhibition of IKs during sympathetic activation leads to the loss of adaptive APD shortening 
(Han et al, 2001) that is further weakened by the activated inward ICa,L current. Animal 
experiments carried out in different species suggest that inhibition of IKs alone does not result 
in significant APD prolongation and ventricular arrhythmias. However, pharmacological 
block of IKs together with IKr inhibition causes excessive APD prolongation (Varró et al, 
2000) and consequent early afterdepolarizations (EAD) leading to malignant ventricular 
arrhythmias (TdP-VT). Thus, IKs does not necessarily contribute to repolarization in normal 
circumstances and low sympathetic tone, but provides a very important protective mechanism 
against APD prolonging agents in pathological settings and represents a significant reserve 
outward current and plays a key role in repolarization reserve (Johnson et al, 2010). The 
density of IKs channels shows transmural and regional heterogeneity (Gintant, 1995): the 
expression is significantly stronger in the subepicardial than in the endocardial layer 
contributing to physiological repolarization heterogeneity already present in normal settings. 
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However, under certain conditions (e.g. heart failure) these expression differences may be 
more pronounced due to electrical remodeling causing significant dispersion of repolarization 
that may lead to increased incidence of malignant arrhythmias. 
 
1.2.5 Inward rectifier potassium current (IK1) 
IK1 flows through Kir2.1, Kir2.2, Kir2.3, Kir2.4 channels (Anumonwo and Lopatin, 
2010; Barry and Nerbonne, 1996; Boyett et al, 1996). Its name (inward rectifier) originates 
from the phenomenon that potassium movement through these channels is larger toward the 
intracellular space than outward direction if membrane potentials are more negative than -90 
mV (Carmeliet, 1993; Harvey and Ten Eick, 1988). However, it is important to note that this 
phenomenon exists only in experimental settings due to the fact that membrane potentials of 
myocytes are more positive than the electrochemical potential of K+ in physiological 
circumstances. Consequently, potassium current also flows into the outward direction through 
these channels. The pore forming units of the inward rectifier potassium current (IK1) are open 
at resting membrane potential during diastole, but the current is decreasing close to zero at 
membrane potentials above -30mV and the channel is reopening very rapidly when the 
membrane potential reaches more negative values (inward rectification) contributing to the 
final repolarization phase. This inward rectification is due to the voltage dependent channel 
inhibition caused by Mg2+ and polyamines (Matsuda et al, 1987). IK1 is fully open at rest that 
plays an important role in the maintenance of the resting membrane potential. As a 
consequence, presumably, the IK1 can oppose any kind of depolarization such as delayed 
afterdepolarisations (DAD) due to calcium overload, preventing the development of 
extrasystoles and its propagation to the surrounding myocardium, therefore IK1 can play an 
important role in repolarization reserve (Varró and Baczkó, 2011). It is considered as a special 
form of repolarization reserve. In addition, impairment of IK1 results in prolonged 
repolarization and more depolarized membrane potential. The density of IK1 shows significant 
differences among species (Jost et al, 2008; Varró et al, 1993): it is strong in dog and rabbit 
but relatively weak in human ventricles. This means that block of IK1 in humans is not 
reflected in significant APD lengthening but inhibition of this current together with other 
repolarizing currents (e.g. IKr) may cause excessively increased repolarization leading to 
development of EADs and malignant ventricular arrhythmias (Ishihara et al, 2009). Regarding 
the regional distribution of IK1 channels, significant differences are found: IK1 is more 
pronounced in endocardial than epicardial layers and stronger in apical than in basal areas 
contributing to repolarization inhomogeneity.  
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1.3 Pro-arrhythmia models based on the impairment of repolarization reserve and 
possible significance of short term QT variability 
Perhaps the most extensively studied in vivo pro-arrhythmia model for drug-induced 
TdP is the dog model featuring chronic atrioventricular block and chronic bradycardia 
(Chezalvier-Guilbert et al., 1995; Vos et al., 1995). In this setting, the downregulation of 
several potassium currents was observed, particularly the downregulation of the slow delayed 
rectifier potassium current (IKs), that plays a vital role in repolarization reserve and 
development of arrhythmias and development of TdP (Volders et al., 1999). Downregulation 
or impairment of IKs current alone did not markedly influence normal ventricular 
repolarization in isolated rabbit, dog and human ventricular preparations but obviously plays 
an important role of repolarization reserve and it can significantly contribute to the safety 
margin of repolarization (Varró et al., 2000; Lengyel et al., 2001; Volders et al., 2003; Jost et 
al., 2005; Abi-Gerges et al., 2006). 
In the same chronic AVB dog model, it was found that QTc prolongation alone did not 
correlate with the pro-arrhythmic potential of drugs (Lawrence 2005) and the markedly 
lengthened QTc interval by IKr block alone did not significantly increase the incidence of TdP. 
These results are similar to that observed in human (van Opstal et al., 2001). This model also 
showed that the incidence or lack of arrhythmia correlated better with the degree of short-term 
variability (STV) of repolarization (Thomsen et al., 2004). 
Several studies suggest that susceptibility to arrhythmias does not dependent only on the 
spatial but it is also influenced by the temporal inhomogeneity of repolarization (Berger et al., 
1997; Hondeghem et al., 2003). Beat-to-beat variability of repolarization (BVR) which is 
quantified as short-term variability (STV), is a novel biomarker that represents the temporal 
dispersion of repolarization duration between consecutive beats. BVR can simply be 
illustrated on a Poincaré plot where each QT or APD value is plotted against its preceding 
value. The greater the covered area on the Poincaré plot the larger the BVR. The BVR has 
been therefore suggested to be calculated in drug safety investigations, expressed as STV. 
This parameter has already been used in dog and rabbit pro-arrhythmia models as well as in 
some small clinical studies, however, broad clinical application is still lacking. It was 
demonstrated in a chronic atrioventricular block dog model (cAVB dog) that the known pro-
arrhythmic drug, D-sotalol, increased both the QTc interval and STVQT, however, amiodarone 
that is less frequently associated with TdP, caused a similar and marked QT prolongation but 
did not increase STV (Thomsen et al., 2004). Nevertheless, numerous studies confirm that 
following administration of safe drugs the STV remains unchanged despite significant QT 
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lengthening whereas pro-arrhythmia is associated with STV prolongation (Thomsen et al, 
2004; Oros et al, 2010; Antoons et al, 2010; Oros et al, 2006;Thomsen et al, 2006; van Opstal 
et al, 2001). Importantly, a large number of TdP episodes were induced only when 
repolarization reserve was previously impaired by chronic atrioventricular block leading to 
remodeled heart or multiple drug administration. In these cases, the occurence of TdP was 
associated with a clear increase in STV. 
Some clinical studies also demonstrated that STVQT was a more promising predictive 
parameter for patients with increased risk for impaired repolarization dependent ventricular 
arrhythmias. Hinterseer at al. have found that in patients known to be at high risk for drug- 
induced TdP, STVQT was two-fold higher than in controls, however, QTc- intervals were 
similar in the two groups (Hinterseer et al., 2008). The results of another study by Hinterseer 
et al. showed that congenital LQTS patients only with manifest tachyarrhythmias had 
significantly increased STVQT in addition to a prolonged QTc interval (Hinterseer et al., 
2009). Similar results were obtained in patients with congestive heart failure and patients with 
implantable cardioverter-defibrillator for secondary prevention whose STVQT values were the 
highest among high risk patients (Hinterseer et al., 2010). An increased STVQT was also 
demonstrated in professional soccer players with athlete’s heart during and after exercise 
despite increased heart rate and decreases heart rate variability (Lengyel at al., 2011) These 
results indicate that STVQT could be a more reliable marker to identify patients with decreased 
repolarization reserve and could be a promising parameter to predict possible malignant 
ventricular arrhythmias in the clinical setting. 
Experiments in our laboratory carried out on a conscious dog and anaesthetized rabbit 
TdP model also showed that increased QTc interval following the administration of the IKr 
blocker dofetilide did not lead to a high incidence of TdP but simultaneous decrease of 
repolarization reserve by application of the IKs blocker HMR 1556 resulted in significant 
increase in STVQT and incidence of TdP (Lengyel et al., 2007). Based on the above it seems 
that the reduction of IKs current and the consequent impairment of repolarization reserve 
either by experimental AV-block (leading to IKs downregulation) or pharmacological IKs 
block, increases arrhythmia susceptibility and increases the incidence of ventricular 
arrhythmia development that can be better predicted by increased STVQT than by simple 
measurements of repolarization prolongation. 
On the other hand, repolarization reserve is not limited to IKs function, and currently 
there is little data on the relative roles of the other potassium currents, such as IK1, in 
repolarization reserve and TdP development. It is important to note species differences 
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regarding to the density of IK1: it is relatively weak in humans (Jost et al., 2008), but strong in 
dog, rabbit and guinea pig (Varró et al., 1993). Impairment of IK1 in humans is not always 
reflected in significant repolarization and QTc prolongation. In LQT7 (Andersen-Tawil 
syndrome), loss of function mutations in Kir2.1 channels significantly decrease IK1 current, 
however, the substantially increased pro-arrhythmic risk in these patients is not accompanied 
by marked QTc prolongation on the ECG (Zhang et al., 2005). However, the impairment of 
repolarization reserve associated with malfunction of IK1 together with the defect of other 
potassium channels, may lead to excessive lengthening of the APD. Computer modeling 
studies also support a key role for IK1 in ventricles: in these models, reduction of IK1 in 
addition to IKr block led to EADs (Ishihara et al., 2009). Nevertheless, there is little animal 
experimental evidence that reduction of repolarization reserve associated with malfunction of 
IK1, actually predisposes the heart to malignant arrhythmias.  
There is considerable variation in the expression of key repolarizing potassium channels 
in different mammalian species, including dog and rabbit that are frequently used species in 
pro-arrhythmia models. Therefore, it is reasonable to assume that species specific ion channel 
expression profiles may result in species dependent alterations in responses to potassium 
channel blockers. Such differences may significantly influence the value of data obtained in 
these models for human extrapolation, however, it is unclear how species specific potassium 
channel expressions translate into differences in arrhythmia development in dogs and rabbits. 
 
1.4 Adaptation of the repolarization to abrupt changes in heart rate 
Disturbances in another important aspect of cardiac ventricular repolarization adaptation 
can also play a significant role in the development of serious cardiac arrhythmias and sudden 
cardiac death. Rapid changes in heart rate are attended by prompt adaptation of QT interval to 
restore the proper steady-state level. Clinical, animal experimental and theoretical studies 
have shown that abrupt changes in heart rate result in a progressive adaptation of the QT 
interval measured on the ECG due to short-term cardiac memory effects. The short-term 
cardiac memory defined as the effect of pacing history on action potential duration (APD) 
(Baher et al., 2007). The term ‘memory’ means a variety of circumstances in which the APD 
of one action potential does not depend simply on the previous action potential (Rosenbaum 
et al. 1982; Gilmour et al. 1997; Shvilkin et al. 1998; Wu & Patwardhan, 2004). A part of 
these changes appear after a few beats while others require hours of stimulation. Cardiac 
memory is identified on the surface ECG as significant change in T- wave polarity that is seen 
when sinus rhythm resumes after a period of abnormal myocardial activation. Currently, 
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although, the ionic mechanisms of short-term cardiac memory are poorly understood, they 
may have important effects on reentry and fibrillation. Grom et al. have demonstrated in a 
clinical study that in the case of slow APD adaptation, the suddenly decreased heart rate, as 
occurs at conversion of atrial fibrillation, the initial APD and QT intervals will be shorter than 
in the steady-state at the new heart rate (Grom et al., 2005). This may make the myocardium 
more susceptible to arrhythmias. Similarly, when heart rate suddenly increases, the initial 
APD and QT will be more prolonged than at steady-state. The prolonged APD is known to be 
a risk for TdP arrhythmia. Patients exhibiting protracted QT interval heart rate adaptation 
dynamics have been identified to be at greater risk for developing cardiac arrhythmias and 
sudden cardiac death. Furthermore, clinical data also suggests that the extent of amiodarone-
induced acceleration of QT interval heart rate adaptation could be used as a therapeutic 
marker of antiarrhythmic drug efficacy (Smetana et al., 2004). Regarding the underlying ionic 
mechanisms that has been extensively studied in cardiac memory is the transient outward 
potassium current (Ito) (Balzo et al., 1992). Changes in ICa,L and IKr are also described in 
cardiac memory (Plotnikov et al., 2003; Obreztchikova et al., 2006). The APD heart rate 
adaptation consist of two phases: a fast initial phase with time constant <30 s, mainly related 
to L-type calcium and slow-delayed rectifier potassium current, and a second slow phase of > 
2 min driven by intracellular sodium concentration ([Na]i) dynamics. However, despite strong 
evidence suggesting an important role of short-term cardiac memory in arrhythmogenesis, the 
underlying ionic mechanisms are still controversial. 
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2. Aims of the study 
 
2.1 Aims of studies on repolarization reserve 
It is not clear, how species specific potassium channel expressions translate into 
differences in arrhythmia development in dogs and rabbits, two species frequently used in 
pro-arrhythmia models. It has been shown previously that repolarization reserve impairment 
by inhibition of IKs increased arrhythmia susceptibility during subsequent IKr inhibition in 
dogs and rabbits in a similar degree. A possibly important role for IK1 has been suggested in 
repolarization reserve. In the first series of experiments we studied the effects of combined 
pharmacological inhibition of IK1 and IKs, as well as IK1 and IKr on ECG parameters and the 
incidence of TdP in conscious dogs and anesthetized rabbits. We also investigated whether 
TdP development was paralleled by increased short-term variability of the QT interval, a 
novel ECG parameter suggested for more reliable prediction of drug-induced ventricular 
arrhythmias. 
 
2.2 Aims of studies on repolarization adaptation to changes in heart rate  
The aim of the second series of experiments was to investigate another important aspect 
of cardiac ventricular repolarization adaptation: we performed studies on the ionic 
mechanisms of QT interval heart rate adaptation in ventricular tissue and their link to pro-
arrhythmic mechanisms. Experiments were carried out to identify the specific mechanisms of 
ionic transport that determine QT interval rate adaptation and how alterations in those 
mechanisms might lead to arrhythmic events. 
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3. Methods 
 
All animal experiments were conducted in compliance with the Guide for the Care and 
Use of Laboratory Animals (NIH Publication No. 85-23, Revised 1996), and the protocol was 
approved by the Ethical Committee for the Protection of Animals in Research of the 
University of Szeged, Hungary (I-74-125-2007 and I-74-5-2012) and by the Department  of  
Animal  Health  and  Food  Control  of  the  Ministry  of Agriculture and Rural Development 
(XIII/01031/000/2008 and XIII/1211/2012). 
 
3.1 Conscious dogs 
Beagle dogs of either sex weighing 10-15 kg were used for the experiments. The 
animals were allowed to accomodate to experimental personnel and equipment, including a 
loosely fitting jacket containing ECG electrodes, every day for a week before the 
commencement of the actual studies. After a 20 min equilibration period, baseline recordings 
were obtained. The animals were then randomly assigned to the following four groups as 
shown on Figure 1:  
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Figure 1. Schematic illustration of drug administration protocols in the different groups of conscious 
dogs.  
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(Group A) 6 dogs received BaCl2 intravenously in three different doses: 0.1 mg/kg, 0.3 mg/kg 
and 1 mg/kg each after a 20 min equilibration period, (Group B) 8 dogs were given 3 mg/kg 
BaCl2 alone, (Group C) 8 dogs were administered 3 mg/kg BaCl2 followed by 25 µg/kg 
dofetilide intravenously after a 10 min equilibration period and (Group D) 6 animals received 
1 mg/kg HMR 1556 followed by 3 mg/kg BaCl2 intravenously after a 10 min equilibration 
period. The drugs were administered during a 5 min continuous i.v. infusion (Terufusion TE-
3, Terumo Europe, Leuven, Belgium). The electrocardiogram was obtained using precordial 
leads and was digitized and stored on a computer for later analysis using National Instruments 
data acquisition hardware (National Instruments, Austin, TX, USA) and SPEL Advanced 
Haemosys software (v3.2, Experimetria Ltd., Budapest, Hungary). The PQ, RR, QT intervals 
were measured as the average of 30 consecutive beats (the minimum number of beats required 
for the calculation of short-term variability of an interval, see below) and the frequency 
corrected QT interval (QTc) was calculated using a formula recommended for Beagle dogs: 
QTc = QT – (0.087 * (RR-1000)) (Tattersall et al., 2006; Van de Water et al., 1989). The 
intervals were measured at the following time points during the experiments: (i) 2 min before 
the start of drug infusion (baseline); (ii) 10 min after the end of drug infusions and (iii) the 
sinus rhythm ECG section directly preceding the arrhythmia if Torsades de pointes (TdP) or 
ventricular tachycardia occurred. 
 
3.2 Anaesthetized rabbits 
Male New Zealand white rabbits (2-3 kg) were used for the experiments. The animals 
were anaesthetized with thiopentone (50 mg/kg i.v.) given into the marginal vein of the right 
ear. A catheter filled with isotonic saline containing 500 IU/ml heparin was inserted into the 
left carotid artery for the measurement of arterial blood pressure. The right jugular vein was 
canulated for subsequent i.v. drug administration. The animals were allowed to stabilize for 
20 min and baseline measurements were taken. The first group of rabbits received 0.1, 0.3 and 
1 mg/kg BaCl2 alone in a volume of 2 ml/kg during a 5 min infusion and each dose were 
given after a 20 min equilibration period. The second group was administered 0.3 mg/kg 
BaCl2 followed by 25 µg/kg dofetilide 20 min after HMR administration. The third group 
received 0.1 mg/kg HMR 1556 followed by 0.3 mg/kg BaCl2 intravenously 20 min after 
HMR administration. (Figure 2): 
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Figure 2. Schematic illustration of drug administration protocols in the different groups of 
anaesthetized rabbits.  
 
The blood pressure and the electrocardiogram (leads I, II and III) were continuously 
recorded (at 200 Hz), digitized and stored on a computer for analysis using National 
Instruments data acquisition hardware (National Instruments, Austin, TX, USA) and SPEL 
Advanced Haemosys software (v3.2, Experimetria Ltd., Budapest, Hungary). The PQ, RR, 
QT intervals were measured as the average of 30 beats (the minimum number of beats 
required for the calculation of short-term variability of an interval, see below). During the 
measurement of the QT interval in anaesthetized rabbits, the guidelines described by Farkas et 
al. (2004) were followed. In animals with a significantly faster heart rate than that of humans 
(e.g. rabbits), QTc calculated with Bazett’s formula does not accurately reflect the heart rate 
dependent changes in QT interval. Therefore, QTc was calculated by a formula specifically 
suggested for anaesthetized rabbits by (Batey & Coker (2002)) as follows: QTc = QT – (0.704 
* (RR-250). 
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3.3 Short-term beat-to-beat variability of the RR and QT intervals 
In order to characterize the instability of beat-to-beat repolarization, Poincaré plots of 
the QT intervals were constructed where each QT value is plotted against its former value in 
dogs and rabbits (Figures 6 and 11). The plots are the result of 30 consecutive interval 
measurements in sinus rhythm at a given time point during the experiments. In the case of 
combined IK1 and IKr or IKs and IK1 block where TdP commonly occurred, the measurements 
were taken prior to the development of TdP. The beat-to-beat short-term variability (STV) of 
RR or QT intervals was calculated using the following formula: STV = ∑|Dn+1-Dn| (30x√2)-1, 
where D is the duration of the QT or RR interval. The STV represents the mean orthogonal 
distance to the line-of-identity on the Poincaré plot, and this estimation of RR and QT interval 
instability is based on previous analysis of the value of qualitative and quantitative Poincaré 
plot examination (Brennan et al., 2001).  
 
3.4 In vitro study 
3.4.1 Standard intracellular microelectrode technique 
Action potential measurements were carried out by applying the standard intracellular 
microelectrode technique in right ventricular papillary muscle preparations isolated from 
mongrel dogs of either sex weighing 12–20 kg. 
After intravenous anaesthesia with thiopentone the hearts were rapidly removed through 
right lateral thoracotomy and placed in oxygenated modified Locke’s solution containing the 
following (in mM): NaCl 120, KCl 4, CaCl2 1.0, MgCl2 1, NaHCO3 22, and glucose 11. The 
pH of this solution was set between 7.35 and 7.4 when saturated with the mixture of 95% O2 
and 5% CO2 at 37oC. 
Papillary muscles were obtained from the right ventricle and mounted in a 50 ml of 
volume tissue chamber. Pacing at cycle length (CL) of 1000 ms, using rectangular pulses of 
1ms duration at twice diastolic threshold in intensity was applied until steady-state through 
bipolar platinum electrodes. Transmembrane potentials were recorded using conventional 
glass microelectrodes filled with 3 M KCL with a tip resistance of 5-20 MΏ. Electrodes were 
captured to the high impedance amplifier (Experimetria, type 309, Budapest, Hungary) which 
was connected to a dual beam oscilloscope. Electrophysiological parameters were measured 
applying the Action Potential Evaluation Software (APES) running on an IBM compatible 
computer and data for action potential duration adaptation were evaluated using the 
EvokeWave software. 
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3.4.2 Measurements of the action potential parameters 
Action potential measurements were carried out using right ventricular papillary 
muscles. Preparations were paced at basic cycle length (BCL) =1000 ms and allowed to 
equilibrate for at least 1h until steady state while superfused with oxygenated Locke’s 
solution. The following parameters were recorded during the experiments: The amplitude of 
the action potential (AMP), the maximum upstroke velocity (Vmax), resting potential and the 
action potential duration at 10%, 25%, 50%, 75% and 90% repolarization (APD10, APD25, 
APD50, APD75 and APD90). After control measurements selective IK1 (30 µM BaCl2), IKr (100 
nM dofetilide), and IKs (1µM HMR 1556) blocker drugs were added to the preparations alone 
and in combination to reduce repolarization reserve. 
 
3.4.3 Measurements of APD adaptation in canine cardiac preparations 
Action potential measurements were carried out by applying the standard intracellular 
microelectrode technique in right ventricular papillary muscle preparations isolated from 
mongrel dogs of either sex weighing 8–20 kg. 
The rate adaptation of the action potential duration at 90% repolarization (APD90) was 
evaluated. Pacing at cycle length (CL) of 1000 ms was applied until steady state, then CL was 
changed stepwise to 600 ms for 10 minutes (acceleration) and back to 1000 ms for an 
additional 10 min (deceleration). Two phases of APD adaptation dynamics were identified: 
APD90 heart rate adaptation following step CL changes consisted of two phases with time 
constants τfast and τslow, calculated from fitting the corresponding portion of APD time course 
with an exponential function: f(t) = a + b e -(t-c)/t .  
Time constants τfast and τslow were obtained both after CL increase and decrease. APD 
HR adaptation was evaluated both in control and in the presence of BaCl2 (30 µM), HMR 
1556 (250 nM), dofetilide (100 nM), ICa,L blocker (1 µM nisoldipin) and INaK blocker (600 nM 
strophantin). 
  
3.5 Compounds 
HMR 1556 (Aventis Pharma, Frankfurt am Main, Germany) was dissolved in 
dimethylsulfoxide (DMSO, 0.1%) as a stock solution of 10 µM. Dofetilide (Gedeon Richter 
Ltd., Budapest, Hungary) was dissolved in saline as a stock solution of 5 µM. BaCl2 was 
dissolved in distilled water as a stock solution of 100 mM. Each stock solution was diluted 
immediately before use. 
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3.6 Statistical analysis 
The incidence of TdP (%) was compared by using the χ2 test with Yates’ correction. All 
other data are expressed as means + standard deviation (SD). Data within groups were 
compared after analysis of variance (repeated measures one-way ANOVA) by Bonferroni’s 
post test and the groups were compared in pairs by means of Student’s “t” test. A level of 
p<0.05 was considered to be statistically significant. 
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4. Results 
 
4.1 Studies on repolarization reserve 
In these experiments, the effects of the combined inhibition of different potassium 
currents on drug-induced TdP and several ECG parameters were investigated in conscious 
dogs and anaesthetized rabbits. 
 
4.1.1 The effect of cumulative doses of BaCl2 alone on RR, QTc interval and STVQT in 
conscious dogs and anaesthetized rabbits 
In order to determine the doses of the IK1 inhibitor BaCl2 to be used in our subsequent 
in vivo experiments, especially in the light of the known species specific differences in the 
composition of ion channels carrying the IK1 current, a series of preliminary experiments were 
performed in conscious dogs and anaesthetized rabbits where cumulative i.v. doses of BaCl2 
were administered with continuous ECG registration and evaluation. BaCl2 was used 
previously in intact dogs in doses up to more than 8 mg/kg (Foster et al., 1977). This dose, 
however, caused arrhythmias and we did not intend to provoke serious arrhythmias by 
administration of BaCl2 alone, therefore we tested 0.1, 0.3, 1 and 3 mg/kg i.v. BaCl2 in both 
dogs and rabbits. Based on these preliminary experiments we chose the applied BaCl2 doses 
in subsequent experiments, that is a BaCl2 dose that did not provoke significant amount of 
ventricular arrhythmias. 
4.1.1.1 Conscious dogs 
Administration of the IK1 blocker BaCl2 alone in conscious dogs significantly decreased 
the heart rate and increased the RR interval in a dose-dependent manner (653.8 ± 69.87 ms, 
809.9 ± 124.99 ms and 891.2 ± 136.54 ms after administration of 0.1 mg/kg, 0.3 mg/kg and 1 
mg/kg BaCl2 vs. 615.6 ± 145.99 ms at baseline, n=6, p<0.05). Interestingly, 3 mg/kg iv. 
infusion of BaCl2 only showed a tendency to prolong RR intervals, however, these differences 
proved to be not significant (797.9 ± 191.23 ms after 3 mg/kg BaCl2 vs. 763.3 ± 138.66 ms at 
baseline, p>0.05). 
In the dose of 0.1 mg/kg BaCl2 alone did not cause statistically significant QTc 
prolongation: 256.8 ± 10.59 ms vs 247.9 ± 7.04 ms at baseline, p>0.05. The pharmacological 
block of IK1 alone by 0.3, 1, and 3 mg/kg BaCl2 resulted in significant QTc prolongation in 
conscious dogs. The QTc intervals yielded the following results: 258.55 ± 15.39 ms after 0.3 
mg/kg BaCl2, 309.52 ±33.10 ms after 1 mg/kg BaCl2 and 334.9 ± 33.26 ms after 3 mg/kg 
  
24 
BaCl2 vs. 247.9 ± 7.04 ms at baseline, n=6, p<0.05. IK1 block alone by 0.1, 0.3, 1 and 3 mg/kg 
BaCl2 did not significantly influence STVQT: 3.2 ± 1.15 ms, 4.1 ± 1.70 ms, 5.3 ± 3.20 ms and 
5.4 ± 1.02 ms vs. 3.8 ± 1.44 at baseline, n=6, all p>0.05. 
 
4.1.1.2 Anaesthetized rabbits 
When administered alone in anaesthetized rabbits, the IK1 blocker BaCl2 (0.1, 0.3 and 1 
mg/kg, i.v.) did not influence the heart rate and RR interval significantly: 234.3 ± 9.29 ms, 
236.1 ± 10.67 ms, 247.4 ± 13.07 ms vs. 225.3 ± 9.11 at baseline, n=7, all p>0.05, 
respectively. The QTc interval was not altered significantly in anaesthetized rabbits by 
cumulative doses (0.1, 0.3 and 1 mg/kg) of BaCl2: 164.8 ± 3.86 ms, 166.8 ± 5.47 ms, 167.9 ± 
4.02 ms vs. control: 161.8 ± 3.84 ms, n=7, all p> 0.05, respectively. There were no significant 
changes in the short-term variability of QT interval using 0.1, 0.3 and 1 mg/kg BaCl2 alone in 
anaesthetized rabbits: 3.1 ± 0.49 ms, 3.4 ± 0.50 ms, 3.5 ± 0.40 ms vs. 2.92 ± 0.56 ms at 
baseline, n=7, all p> 0.05, respectively. 
 
4.1.2 Effect of combined IK1 and IKr inhibition on RR and QTc intervals in conscious 
dogs and anesthetized rabbits 
Both in dogs and rabbits, the administration of the IK1 inhibitor BaCl2 alone did not 
change heart rate and the RR intervals (Figure 3). However, infusion of the IKr inhibitor 
dofetilide significantly increased RR intervals (Figure 3) and decreased heart rate (dogs: 66.9 
± 16.96 vs. 80.5 ± 12.12 beats/min in control; rabbits: 213.9 ± 1.92 vs. 258.6 ± 1.26 beats/min 
in control, p<0.05) in both species. 
 
 
 
Figure 3. Effect of IK1 inhibition (i.v. BaCl2) and combined IK1+IKr (i.v. BaCl2+dofetilide) inhibition 
on RR intervals in conscious dogs and anesthetized rabbits. n=7 dogs and 7 rabbits/group; *p<0.05 vs. 
control values. 
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In our previous study, the IKr inhibitor dofetilide administered alone did not alter the RR 
interval but as expected, significantly prolonged the QTc interval in conscious dogs and 
anesthetized rabbits (Lengyel et al. 2007). In conscious dogs, IK1 inhibition significantly 
prolonged the frequency corrected QT interval, calculated with the Van de Water formula 
(Van de Water et al., 1989), and dofetilide infusion caused a further, significant prolongation 
of the QTc interval (Figure 4 left panel). The uncorrected QT intervals yielded similar 
prolongation: 317.4 ± 47.9 ms after IK1 block and 373.5 ± 37.8 ms after combined IK1+IKr 
inhibition vs. 221.4 ± 11.7 ms in controls, (p<0.05). In anesthetized rabbits, only the 
combination of IK1 and IKr inhibition resulted in significant QTc interval prolongation (Figure 
4 right panel). Again, the uncorrected QT intervals showed a similar prolongation only after 
combined IK1+IKr inhibition (150.6 ± 5.88 ms after IK1 inhibition and 167.8 ± 6.27 ms after 
BaCl2 and dofetilide combination vs. 147.2 ± 5.46 ms in control). 
 
 
 
 
Figure 4. Effect of IK1 inhibition (i.v. BaCl2) and combined IK1+IKr (i.v. BaCl2+dofetilide) inhibition 
on frequency corrected QT interval (QTc) in conscious dogs and anesthetized rabbits. n=7 dogs and 7 
rabbits/group; *p<0.05 vs. control values; #p<0.05 vs. IK1 inhibition. 
 
4.1.3 Effect of combined IK1 and IKr inhibition on the short-term variability of RR 
(STVRR) and QT intervals (STVQT) in conscious dogs and anesthetized rabbits 
Since heart rate affects repolarization duration, the short-term variability of the RR 
intervals were also calculated in addition to STVQT, the ECG parameter recently suggested for 
more reliable prediction of ventricular arrhythmias. In conscious dogs, STVRR did not change 
significantly following IK1 and combined IK1+IKr inhibition (Figure 5 left panel). In 
anesthetized rabbits, the combination of BaCl2 and dofetilide slightly, but significantly 
increased STVRR, however, the magnitude of these changes (less than 0.5 ms) makes it very 
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unlikely that this STVRR change markedly influenced repolarization variability (Figure 5 
right panel). 
 
 
 
Figure 5. Effect of IK1 inhibition (i.v. BaCl2) and combined IK1+IKr (i.v. BaCl2+dofetilide) inhibition 
on the short-term variability of the RR interval (STVRR) in conscious dogs and anesthetized rabbits. 
n=7 dogs and 7 rabbits/group; *p<0.05 vs. control values. 
 
The IKr inhibitor dofetilide, when administered alone did not alter STVRR in conscious 
dogs and anesthetized rabbits in our previous study (Lengyel et al. 2007). The Poincaré plots 
on Figure 6 illustrate repolarization temporal instability in two individual animals, a 
conscious dog (left panel) and an anesthetized rabbit (right panel) following IK1 and 
combined IK1+IKr inhibition. 
 
 
 
 
 
Figure 6. Illustration of the effect of IK1 inhibition (i.v. BaCl2) and combined IK1+IKr (i.v. 
BaCl2+dofetilide) inhibition on short-term variability of the QT interval (STVQT) in a representative 
conscious dog (left panel) and an anesthetized rabbit (right panel). For details on Poincaré plot 
description please refer to the text. 
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Both animals exhibited TdP arrhythmia as a result of BaCl2 and dofetilide combination, and 
the scatter of data points covering a large area on the plot following this combination 
represents large STVQT values in these animals (15.8 ms in the dog and 4.9 ms in the rabbit). 
Grouped STVQT data showed a significant increase in both species following combined 
IK1+IKr inhibition (Figure 7). Dofetilide alone did not increase STVQT in conscious dogs, 
however, it significantly increased STVQT in anesthetized rabbits in our previous study 
(Lengyel et al. 2007). 
 
 
 
Figure 7. Effect of IK1 inhibition (i.v. BaCl2) and combined IK1+IKr (i.v. BaCl2+dofetilide) inhibition 
on short-term variability of the QT interval (STVQT) in conscious dogs (left panel) and anesthetized 
rabbits (right panel). n=7 dogs and 7 rabbits/group; *p<0.05 vs. control values. 
 
4.1.4 Effect of combined IKs and IK1 block on RR and QTc intervals in conscious dogs 
and anesthetized rabbits 
The IKs inhibitor HMR 1556 did not change the RR interval significantly in conscious 
dogs or anesthetized rabbits, and this result was in good agreement with our previous 
observations (Lengyel et al., 2007). The combined inhibition of IKs+IK1, however, caused a 
significant increase in RR intervals and decrease in heart rate in rabbits only (Figure 8 right 
panel). 
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Figure 8. Effect of IKs inhibition (i.v. HMR 1556) and combined IKs+IK1 (i.v. HMR 1556+BaCl2) 
inhibition on RR interval in conscious dogs and anesthetized rabbits. n=6 dogs and 7 rabbits/group; 
*p<0.05 vs. control values. 
 
In conscious dogs, IKs inhibition significantly increased the frequency corrected QT interval, 
similarly to our previous observations in conscious dogs (Lengyel et al., 2007). In these 
animals, subsequent infusion of BaCl2 caused a further, significant QTc prolongation (Figure 
9 left panel). 
 
 
 
 
Figure 9. Effect of IKs inhibition (i.v. HMR 1556) and combined IKs+IK1 (i.v. HMR 1556+BaCl2) 
inhibition on frequency corrected QT interval (QTc) in conscious dogs and anesthetized rabbits. n=6 
dogs and 7 rabbits/group; *p<0.05 vs. control values; #p<0.05 vs. IKs inhibition. 
 
The uncorrected QT intervals showed similar prolongation: 317.5 ± 35.2 ms after IKs block 
and 387.4 ± 45.4 ms after combined IKs+IK1 inhibition vs. 230.5 ± 7.6 ms in controls, 
(p<0.05). In anesthetized rabbits, IKs inhibition did not alter QTc, and combined IKs+IK1 
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inhibition only had a slight tendency to increase QTc but this change did not prove to be 
statistically significant (Figure 9 right panel). 
 
4.1.5 Effect of combined IKs and IK1 inhibition on the short-term variability of RR 
(STVRR) and QT (STVQT) intervals in conscious dogs and anesthetized rabbits 
HMR 1556 did not alter STVRR in conscious dogs or anesthetized rabbits. The 
combined inhibition of IKs+IK1 caused a significant, but again, very small (less than 1 ms) 
increase in STVRR in anesthetized rabbits (Figure 10 right panel). 
 
 
 
Figure 10. Effect of IKs inhibition (i.v. HMR 1556) and combined IKs+IK1 (i.v. HMR 1556+BaCl2) 
inhibition on short-term variability of the RR interval (STVRR) in conscious dogs and anesthetized 
rabbits. n=6 dogs and 7 rabbits/group; *p<0.05 vs. control values. 
 
The Poincaré plots on Figure 11 illustrate repolarization temporal instability in two individual 
animals, a conscious dog (left panel) and an anesthetized rabbit (right panel) following IKs 
and combined IKs+IK1 inhibition. The shift of QT interval data points to the right and upward 
direction in the conscious dog represent the above described QT prolongation following HMR 
1556 administration. Careful evaluation of the plot reveals that in this animal, that later 
developed TdP after combined IKs+IK1 inhibition, the QT variability only increased after 
HMR 1556 and BaCl2 combination (Figure 11 left panel). 
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Figure 11. Illustration of the effect of IKs inhibition (i.v. HMR 1556) and combined IKs+IK1 (i.v. HMR 
1556+BaCl2) inhibition on short-term variability of the QT interval (STVQT) in a conscious dog (left 
panel) and an anesthetized rabbit (right panel). For details on Poincaré plot description please refer to 
the text. 
 
In accordance with grouped STVQT data represented on Figure 12 (right panel), in the 
representative rabbit on Figure 11 (right panel) STVQT did not increase significantly after 
HMR 1556 or HMR 1556+BaCl2 combination in anesthetized rabbits. In contrast, in 
conscious dogs this combination led to a significant increase in STVQT (Figure 12 left panel). 
 
 
 
 
Figure 12. Effect of IKs inhibition (i.v. HMR 1556) and combined IKs+IK1 (i.v. HMR 1556+BaCl2) 
inhibition on short-term variability of the QT interval (STVQT) in conscious dogs (left panel) and 
anesthetized rabbits (right panel). n=6 dogs and 7 rabbits/group; *p<0.05 vs. control values; #p<0.05 
vs. IKs inhibition. 
 
 
Importantly, in parallel to this STVQT increase, conscious dogs responded to combined IKs+IK1 
inhibition with significantly increased TdP incidence, while only one of 7 rabbits developed 
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TdP following this combination (Figure 13), and the rabbit grouped data did not show 
elevated STVQT. 
 
4.1.6 Effect of combinations of IK1 and IKr inhibition, and IKs and IK1 inhibition on the 
incidence of TdP in conscious dogs and anesthetized rabbits 
As shown on Figure 13, inhibition of IK1 or IKs alone did not provoke TdP in any of the 
animals. 
 
 
 
 
Figure 13. Effect of IK1 inhibition (i.v. BaCl2) and combined IK1+IKr (i.v. BaCl2+dofetilide) inhibition 
(top panels) and IKs inhibition (i.v. HMR 1556) and combined IKs+IK1 (i.v. HMR 1556+BaCl2) 
inhibition (bottom panels) on the incidence of Torsades de Pointes (TdP) chaotic ventricular 
tachycardia in conscious dogs (left panels) and anesthetized rabbits (right panels). n=7 and 6 dogs, and 
7 rabbits/group; *p<0.05 vs. control values. 
 
We have shown previously that the IKr inhibitor dofetilide alone did not cause TdP in 
conscious dogs and caused TdP in 25% of anesthetized rabbits (Lengyel et al., 2007). 
Combined inhibition of repolarizing currents, however, led to a significant amount of TdP 
episodes in both species, albeit in a different manner. Interestingly, conscious dogs and 
anesthetized rabbits exhibited different TdP incidence following the combined inhibition of 
key potassium currents: a significant amount of conscious dogs developed TdP following 
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IKs+IK1 inhibition, while only one rabbit developed TdP after this combination. On the other 
hand, TdP incidence increased significantly following IK1+IKr inhibition in rabbits, while only 
one dog exhibited TdP following BaCl2+dofetilide administration (Figure 13). 
 
4.1.7 In vitro studies 
 
4.1.7.1 Effect of combined IK1 and IKr block on action potential parameters in dog right 
ventricular papillary muscle 
As shown on Figures 14 and 15, administration of 30 µM BaCl2 and 100 nM 
dofetilide alone has significantly prolonged the action potential duration at 90% repolarization 
(APD90). (Control vs. 30 µM BaCl2: 229.9 ± 35.22 ms vs. 285.5 ± 42.75 ms, p<0.05; control 
vs. 100 nM dofetilide: 221.4 ± 23.34 ms vs. 290.8 ± 42.75 ms, p<0.05 respectively). 
 
Figure 14. The effect of IK1 inhibition alone (by 30 µM BaCl2) and combined IK1 and IKr inhibition (by 
30 µM BaCl2 + 100 nM dofetilide) on action potential duration at 90% repolarization (APD90) in dog 
right ventricular papillary muscle. The IK1 blocker BaCl2 significantly prolonged APD90. Dofetilide 
caused further and marked APD90 lengthening when IK1 was previously inhibited. n= 5; *p<0.05 vs. 
control, #p<0.05 vs. IK1 block. 
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Figure 15. The effect of IKr inhibition alone (by 100 nM dofetilide) and combined IKr and IK1 
inhibition (by 100 nM dofetilide + 30 µM BaCl2) on action potential duration at 90% repolarization 
(APD90). in dog right ventricular papillary muscle. When dofetilide was administered first, BaCl2 
(combined IKr and IK1 block) led to larger APD lengthening than observed on Figure 14 where BaCl2 
was given first. n= 10; *p<0.05 vs. control, #p<0.05 vs. IKr block. 
 
 
Further increase of APD90 was observed in the case of combined IK1 and IKr block: 100 
nm dofetilide caused marked and further APD90 prolongation when IK1 was first blocked by 
30 µM BaCl2 and IK1 inhibition resulted in significant further APD90 prolongation when IKr 
was first blocked by 100 nM dofetilide (control vs. 100 nM dofetilide followed by 30 µM 
BaCl2: 229.9 ± 35.22 ms vs. 326.5 ± 27.52 ms, p<0.05; control vs. 30 µM BaCl2 followed by 
100 nM dofetilide: 221.4 ± 23.34 ms vs. 399.5 ± 79.92 ms, p<0.05 respectively.) 
Interestingly, the repolarization changes tended to be greater when IKr was first blocked than 
in the case of IK1 block followed by administration of dofetilide, as illustrated on Figure 16. 
However, these differences were not statistically significant. 
In summary, cardiac ventricular repolarization duration was increased by IKr or IK1 
block alone and further marked and significant prolongation was observed in the case of 
combined IKr + IK1 block at 1000 ms basic cycle length. 
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Figure 16. Representative action potentials constructed from an individual dog right ventricular 
papillary muscle. The left panel demonstrates the effect of IK1 block (30 µM BaCl2) and combined IK1 
and IKr (100 nM dofetilide) block on action potential when BaCl2 was administered first. The right 
panel shows representative recordings where dofetilide was administered first, followed by IK1 
inhibition by BaCl2. 
 
 
Figures 17 and 18 illustrate the frequency dependent changes of APD90 following the 
administration of 30 µM BaCl2, 100 nM dofetilide alone, and their combination. Both BaCl2 
and dofetilide alone prolonged repolarization in a reverse use dependent manner, however, 
combined IKr + IK1 block caused more pronounced and excessive APD90 lengthening at slow 
heart rates (see cycle lengths 2000, 3000 and 5000 ms). 
 
 
Figure 17. Frequency dependent effect of IK1 block alone on dog right ventricular papillary muscle. 30 
µM BaCl2 increased the APD that was more pronounced at slow heart rates. *p<0.05 vs. control, n= 
11 
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Figure 18. Frequency dependent effect of combined IKr and IK1 block on dog right ventricular 
papillary muscle. Inhibition of IKr alone with 100 nM dofetilide prolonged the APD in frequency 
dependent manner. Additional block of IK1 with 30 µM BaCl2 marked APD elongation occurred 
especially at slow heart rate (reverse frequency dependence). *p<0.05 vs. control, #p<0.05 vs. IKr 
block, n= 7 
 
4.1.7.2 Effect of combined IKs and IK1 block on action potential parameters in dog right 
ventricular papillary muscle 
The effect of the IKs blocker HMR 1556 and the IK1 blocker BaCl2 on the action 
potential in canine papillary muscle is shown on Figure 19. 
 
 
Figure 19. The effect of combined IKs and IK1 block on dog right ventricular papillary muscle at basic 
cycle length of 1000 ms. Reduction of repolarization reserve with the IKs blocker HMR 1556 alone 
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resulted in slight (but statistically significant) APD90 prolongation. Additional inhibition of IK1 by 
BaCl2 caused marked APD90 increase. *p< 0.05 vs. control, #p<0.05 vs. IKs block, n= 17. On the right 
panel representative action potentials constructed from an individual dog right ventricular papillary 
muscle at BCL= 1000 ms are shown in control, following IKs and combined IKs + IK1 block.  
 
 
Small but statistically significant action potential lengthening was induced by 1 µM 
HMR 1556 at a basic stimulation frequency of 1 Hz (from 226.1 ± 5.54 ms to 238.5 ± 6.82 
ms, n=17, p<0.05). In the presence of 1 µM HMR 1556, 30 µM BaCl2 was added to these 
preparations. The drug induced a marked further lengthening relative to the APD90 values 
measured after the administration of HMR 1556 (BaCl2: 306.3 ± 7.17 ms vs. HMR 1556: 
238.5 ± 6.82 ms, n=17, p<0.05), ie. the APD lengthening effect of BaCl2 was significantly 
augmented in preparations where the repolarization reserve was attenuated by previous 
application of HMR 1556. Under these circumstances the combined IKs + IK1 block produced 
reverse rate-dependent APD prolongation (Figure 20). 
 
 
 
 
Figure 20. Frequency dependent effect of combined IKs and IK1 block on dog right ventricular 
papillary muscle. Attenuated repolarization reserve with IKs block alone did not result in significant 
APD prolongation in reverse frequency dependent manner, however, additional block of IK1 caused 
marked and significant APD90 prolongation at slow heart rates. *p< 0.05 vs. control, #p<0.05 vs. IKs 
block, n= 17. 
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Administration of the IKs blocker HMR 1556 alone (1 µM) did not cause significant 
frequency dependent APD90 changes on canine papillary muscle. However, with additional 
block of IK1 these changes got more pronounced in a reverse frequency dependent manner 
(Figure 20). In some experiments arrhythmias developed in this setting. 
 
4.2 Results of studies on repolarization adaptation to changes in heart rate 
 
4.2.1 The effects of IK1, IKs, IKr ICa,L and INaK current inhibition on APD heart rate adaptation 
Clinically, the slow adaptation of QT interval to abrupt changes in heart rate (HR), 
also termed short term cardiac memory, has been proposed as an indicator of arrhythmic risk 
and sudden cardiac death. In the present study, we investigate the ionic basis of action 
potential duration at 90% repolarization (APD90) rate adaptation, which is the cellular 
manifestation of QT heart rate adaptation dynamics. 
The results show that the APD heart rate adaptation consists of two phases: a fast 
initial phase with time constant τfast 12.9 ± 2.25 / 15.8 ± 3.87 s and a second slow phase with 
time constant τslow 176.1 ± 43.41 / 226.1± 51.78. 
Following IK1 current inhibition by 30 µM BaCl2 decreased τfast values were measured 
(Figure 21).  
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Figure 21. The effect of IK1 block on APD90 heart rate adaptation. Experimental (top panels) and 
simulation (bottom panels) study. During acceleration no changes were observed under the effect of 
IK1 block with 30 µM BaCl2. IK1 block decreased the τfast value during deceleration, however, these 
changes were not statistically significant. n= 5 
 
During acceleration the adaptation kinetics remained unchanged but τfast decreased 
from 18.0 ± 3.97 s to 10.8 ± 0.37 s by slowing the heart rate from CL 600 ms to CL 1000 ms. 
There were opposite changes in the adaptation kinetics after IK1 block in the observations of 
experiments and human simulations. In computer simulations the adaptation was slower 
(slightly elevated τslow values) as shown on Figure 21 (bottom left panel), but in the 
experiment it began faster (reduced τfast values in deceleration). 
By inhibition of the IKs current in the computer simulation study (Figure 22 bottom 
panels) decresed τfast values were measured, while there were no clear changes in the  
experiments with 0.25 µM HMR1556 (Figure 22 top left and right panel). The τfast values 
slightly increased from 19.9 ± 7.92 s to 24.1 ± 4.77 s during deceleration under the effect of 
IKs inhibition impairing the ability of APD adaptation to heart rate changes. In contrast with 
experiment, an opposite effect was observed in the computer simulation study where τfast 
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values were decreased during acceleration and deceleration as shown on Figure 22 bottom 
panels. 
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Figure 22. The effect of IKs block on APD90 adaptation kinetics. Experimental (top panel) and 
computer simulation study (bottom panel). No changes were observed during acceleration in the τfast 
values using 0.25 µM HMR 1556. IKs inhibition increased the τfast values and delayed the adaptation of 
repolarization during deceleration. The changes were not found to be significant. Data from computer 
simulation shows an opposite effect (bottom right panel). n= 5 
 
The APD adaptation kinetics remained unchanged after IKr block both in simulation 
and in experiments with application of 100 nM dofetilide. (Figure 23) 
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Figure 23: The effect of IKr block on the APD90 adaptation to heart rate changes. There was no 
alteration under the effect of 100 nM dofetilide in the τfast value in experimental circumstances (top 
panels). Concurrently, computer simulation also shows no significant changes in APD HR adaptation 
(bottom panels). n= 5 
 
In the case of ICa,L inhibition experiments and computer simulations have provided 
different results: τfast values were decreased during acceleration and deceleration from 11.8 ± 
1.89 s / 13.6 ± 2.34 s to 8.8 ± 1.95 s / 11.1 ± 1.18 s in experiments associated with faster APD 
adaptation to heart rate changes, while slower adaptation was present in the computer 
simulation (see the table on Figure 24 bottom right panel). No changes were detected in the 
slow adaptation phase both in the simulation or experiments. 
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Figure 24. The effect of ICa,L inhibition on APD HR adaptation. Experimental results are shown on the 
top panels and simulation study results on the bottom panels. The table indicates the results of the 
simulation study. n=5 
 
Figure 25 shows the effect of NaK pump inhibition in the presence of 0.6 µM 
strophantin-G: τslow values were increased to 258.3 ± 38.08s / 448.9 ± 71.22 s compared with 
control: 161.1 ± 50.52 s / 245.2 ± 54.07 s, but no changes were observed in the initial fast 
phase APD adaptation. The τslow values from the simulation study are presented on the right 
bottom panel of Figure 25. In this case the experiments were confirmed by the computer 
simulation study. 
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Figure 25. The effect of INaK inhibition on APD heart rate adaptation. Experimental results are shown 
on the top panels and simulation study results on the bottom panels. 
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5. Discussion 
 
5.1 Studies on repolarization reserve 
Here we investigated the effects of repolarization reserve impairment by 
pharmacological inhibition of IK1 in combination with IKs and IKr on the incidence of the 
typical drug-induced arrhythmia, TdP, and different ECG parameters, in a similar 
experimental setup to a previously published study of out laboratory where the effects of the 
combined pharmacological inhibition of IKs and IKr were characterized in conscious dogs and 
anesthetized rabbits (Lengyel et al., 2007). In this study we show that combined 
pharmacological inhibition of other repolarizing potassium currents also leads to 
repolarization reserve impairment and high incidence of TdP in conscious dogs and 
anesthetized rabbits. However, dogs and rabbits exhibited markedly different patterns of TdP 
development in response to combined IK1+IKr and IKs+IK1 inhibition suggesting that at least 
some of these currents may play different relative roles in repolarization reserve in dogs and 
rabbits. In contrast, a previous investigation by our laboratory found that both species 
responded with a high incidence of TdP paralleled by significant increases of short-term 
variability of the QT interval following combined IKs+IKr inhibition, irrespective of the 
sequence of IKs and IKr blocker administration (Lengyel et al., 2007). 
The key role of IKs in ventricular repolarization reserve has been well established in 
different animal species as well as in humans (Volders et al. 1999; Varró et al. 2000; Lengyel 
et al. 2001; Volders et al. 2003; Jost et al. 2005; Abi-Gerges et al. 2006; Lengyel et al. 2007; 
Jost et al., 2007; Johnson et al., 2010). However, a recent study highlighted that due to lower 
IKs densities in human hearts, repolarization reserve may be reduced in humans compared to 
dogs (Jost et al., 2013). Attributed to low-level IKs beta-subunit minK expression, a small IKs 
and increased TdP susceptibility were described in rabbits (Lu et al., 2001; Zicha et al., 2003). 
In a recent comparative study, the kinetics of rabbit IKs have been found more human-like 
compared to IKs in guinea-pigs and dogs (Jost et al., 2013b). These data indicate that despite 
the relatively well characterized role of IKs in repolarization reserve, the significant 
differences described in IKs subunit expression, current densities and kinetics in rabbits and 
dogs make human extrapolation of results somewhat difficult. 
The roles other repolarizing potassium currents may play in repolarization reserve are 
poorly understood. Among these repolarizing potassium currents, possible roles for Ito (Virag 
et al., 2011) and IK1 (Biliczki et al., 2002; Varró and Baczkó, 2011) in repolarization reserve 
have been suggested. In LQT7 (Andersen-Tawil syndrome), loss of function mutations in 
  
44 
Kir2.1 channels may significantly decrease IK1 current, however, the substantially increased 
pro-arrhythmic risk in these patients is not accompanied by marked QTc prolongation on the 
ECG (Zhang et al., 2005). Computer modelling studies also support a key role for IK1 in 
ventricles: in these models, reduction of IK1 in addition to IKr block led to early 
afterdepolarizations (Ishihara et al., 2009). A variety of channel subtypes can be responsible 
for the IK1 current, including alpha-subunits Kir2.1, Kir2.2, Kir2.3, Kir2.4 (for a recent review 
see Anumonwo and Lopatin, 2010). Significant species-specific differences in the expression 
of Kir2.x proteins have been reported previously (Wang et al., 1998; Melnyk et al., 2002; 
Dhamoon and Jalife, 2005). Different heteromeric assembly of Kir2.x proteins leads to 
different IK1 characteristics (Dhamoon et al., 2004) and most likely, to altered overall cardiac 
electrophysiological responses to drugs. In rabbit cardiomyocytes, a heteromeric assembly of 
Kir2.1 and Kir2.2 was shown (Zobel et al., 2003). In dogs, Kir2.2 and Kir2.4 levels were 
minimal, while in humans, Kir2.3 mRNA expression was on a similar level to Kir2.1 and 
Kir2.1 mRNA expression was found to be three times higher in dogs compared to human 
(Jost et al., 2013). 
In the present study, the short-term variability of the QT interval was calculated to 
assess temporal instability of repolarization following pharmacological inhibition of 
repolarizing potassium currents. The STVQT characterizes differences in QT interval durations 
of consecutive heart beats and has been suggested as a more reliable measure of pro-
arrhythmic risk associated with impaired repolarization reserve compared to conventional 
ECG parameters of repolarization (Berger et al 2003; Varkevisser et al 2012). In this regard, a 
number of previous in vivo and in vitro animal experimental and clinical studies (van Opstal 
et al., 2001; Thomsen et al., 2004; Lengyel et al 2007; Hinterseer et al., 2009; Hinterseer et 
al., 2010; Antoons et al., 2010) found that STVQT was increased and showed a better 
correlation with subsequent arrhythmias than QT prolongation in animals or individuals with 
decreased repolarization reserve later exhibiting serious ventricular arrhythmias. We found in 
this study that combined inhibition of IK1 + IKr and IKs + IK1 led to increased STVQT in parallel 
with increased incidence of TdP in most cases, further supporting the role of STVQT 
determination in ventricular arrhythmia risk estimation. It should be noted that in dogs, 
following IK1 + IKr inhibition a significant increase in STVQT was found with only one animal 
showing TdP, however, very short episodes of nonsustained monomorphic ventricular 
tachycardia were observed in three additional animals. 
In the in vivo canine TdP model arrhythmias mostly developed following combined IKs 
+ IK1 block, however, following combined IKr + IK1 inhibition a considerable amount of 
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arrhythmias were not observed. The expression of channel proteins determining the different 
potassium currents show significant regional (apico-basal, interventricular and atrio-
ventricular) and transmural heterogeneity within the myocardium. The density of IK1 is higher 
in the endocardium than epicardium, more potent in the right ventricle than in the left 
ventricle and more expressed in the apical area than in the basal region (Furukawa et al., 
1992; Varro et al., 1993; Brunet et al., 2004; Panama et al., 2007; Dhamoon et al., 2004; Giles 
et al., 1988; Melnyk et al., 2002). The differences in the delayed rectifier potassium currents 
are attributable more to IKs than IKr. The IKs current is stronger in the subepicardial than in the 
subendocardial region (Gintant 1995). These transmural and regional differences already 
produce an electrical heterogeneity within the myocardium in physiological circumstances. 
Consequently, since regional differences in IKs may contribute to electrical inhomogeneity in 
a greater degree than IKr, combined block of IK1 + IKs can presumably produce more expressed 
repolarization heterogeneity leading to the development of reentry arrhythmias more so than 
in the setting of combined IKr + IK1 block. Moreover, contribution of the IKs to cycle length 
dependent changes of cardiac repolarization is more important than that of IKr. Consequently, 
the potent respiratory arrhythmia existing in conscious dogs may lead to more excessive 
regional differences in refractory periods following combined IKs + IK1 block than in the case 
of combined IKr + IK1 block. 
In normal circumstances, conscious dogs show marked respiratory sinus arrhythmia 
and have larger STVRR and larger STVQT compared to anaesthetized rabbits that exhibited no 
respiratory arrhythmia and had smaller STVRR and STVQT at baseline. These observations 
raise the possibility that increased STVRR contributes to STVQT changes in our models. 
However, following combined potassium current block where STVQT was increased there 
were no obvious changes in STVRR and a clear influence of STVRR on STVQT was not 
observed in accordance with previous studies (Thomsen et al., 2007; Lengyel et al. 2011) 
have also demonstrated in professional soccer players that STVQT remained increased after 
exercise despite a decrease in heart rate variability. In our experiments, increased STVQT was 
found after combined potassium current inhibition despite unchanged STVRR in dogs, and the 
STVRR increases in rabbits were less than, or around 0.5 ms, making it very unlikely that 
STVRR changes importantly contributed to STVQT alterations. 
In our in vitro studies on repolarization reserve using dog right ventricular papillary 
muscle preparations, inhibition of IK1 and IKs alone caused a significant APD90 prolongation in 
a similar degree to the QTc prolongation observed in conscious dogs (Figures 14, 19, 4 and 
9). Combined inhibition of IK1 + IKr and IKs + IK1 caused a further significant prolongation of 
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repolarization both in vivo and in vitro (Figures 15, 19, 4 and 9). Interestingly, in our in vitro 
study when IKr inhibition was followed by combined IKr + IK1 inhibition, the APD90 
prolongation was larger compared to the experiments where IK1 was blocked first followed by 
combined IK1 + IKr inhibition (Figures 14 and 15). The reasons for these observations are not 
understood, different adaptation mechanisms of repolarization to IKr and IK1 block may be 
involved. The similar degree in repolarization prolongation and the markedly different TdP 
incidence in conscious dogs (Figure 13) following different potassium channel block 
combinations again highlight the importance of calculation of STVQT for more reliable drug-
induced arrhythmia prediction. The frequency dependent prolongation of APD90 following 
inhibition of different potassium channels was also evaluated. Inhibition of IK1 and IKr alone 
led to more pronounced APD90 prolongation at slow heart rates (increased CL) as shown on 
Figures 17 and 18, however, this reverse frequency dependent prolongation was not observed 
after IKs block (Figure 20). Combined IKr + IK1 inhibition resulted in a greater reverse 
frequency dependent APD90 prolongation compared to combined IKs + IK1 block (Figures 18 
and 20). Inhibition of IK1, IKr or IKs did not cause any extra “arrhythmic” beats in the in vitro 
experiments, similarly to our observations in conscious dogs where these interventions did not 
cause severe ventricular arrhythmias, only some extrasystoles (following BaCl2 and 
dofetilide) and/or salvos (following dofetilide). In parallel with the in vivo results, where 
combined potassium current inhibition led to serious ventricular arrhythmias, combined IKr + 
IK1 inhibition and IKs + IK1 block provoked extra beats (beats without stimulation) in canine 
papillary muscle preparations, and these arrhythmic beats occurred more frequently at CL 
3000 ms and CL 5000 ms. Although repolarization was excessively prolonged in these 
circumstances, early afterdepolarisations (EADs) were not observed using the conventional 
microelectrode technique. Previous studies suggest that resting membrane potential of 
ventricular myocytes is maintained by the high resting potassium permeability which flows 
mainly through IK1 (Nichols et al., 1997). By blocking the IK1 in combination with other 
repolarizing currents, enhanced automaticity can occur causing ectopic firing. On the basis of 
our in vitro experiments, enhanced automaticity and ectopic beats may play an important role 
in arrhythmia generation following combined potassium current block involving IK1. 
However, experiments using mathematical modeling, inhibition of IK1 with combination of IKr 
reduction resulted in EADs (Ishihara et al., 2009). The study of Nattel and Quantz suggests 
that cardiac Purkinje fibers are the likely source of early afterdepolarizations initiating TdP 
(Nattel & Quantz, 1988). It is possible that IK1 block in combination with other potassium 
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currents inhibition results in formation of EADs in Purkinje fibers, a scenario present in our in 
vivo setup but not in the in vitro experiments. 
 In summary, due to stronger IK1 and IKs in dogs compared to rabbits and humans, dogs 
may exhibit larger repolarization reserve compared to the other two species. Therefore, rabbit 
pro-arrhythmia models based on pharmacologically impaired repolarization reserve may 
represent greater arrhythmia susceptibility and may be more useful than canine models in 
predicting human electrophysiological responses to drugs affecting cardiac ventricular 
repolarization. 
 
5.2 Studies on adaptation of repolarization to abrupt changes in heart rate 
Clinically, the slow adaptation of QT interval to abrupt changes in heart rate (HR), 
also termed short-term cardiac memory (Arnold et al, 1982; Grom et al, 2005), has been 
proposed as an indicator of arrhythmic risk and sudden cardiac death. Clinical studies suggest 
that patients with elongated QT heart rate adaptation dynamics have an increased risk of 
experiencing cardiac arrhythmias and sudden cardiac death (Grom et al, 2005; Pueyo et al, 
2004). In the present study we investigated the ionic basis of APD90 rate adaptation which is 
the cellular manifestation of QT heart rate adaptation dynamics. APD adaptation is defined as 
protracted when the associated time constant τfast or τslow is abnormally long. In the present 
experiments, 30 µM BaCl2 (estimated 80% IK1 block) results in a 28/11% decrease in τfast 
(Figure 21). Opposite changes in the adaptation kinetics after IK1 block were obtained using 
computer simulation in our cooperative study (Pueyo et al, 2010). Convincing evidence was 
not found in the present experiments that the block of IK1 may significantly influence the 
initial fast phase of APD heart rate adaptation and may lead to arrhythmias via this 
mechanism. However, in both simulation and experiments in dog, IK1 block was found to have 
an impact on the slow phase of APD heart rate adaptation. Block of IK1 led to 30 % decrease 
in τslow in dogs. Consequently, the IK1 block alone is not likely to significantly contribute to 
arrhythmogenesis by slowing the APD and QT adaptation to heart rate changes. It is possible 
that IK1 block in combination with other repolarizing currents indirectly affects the 
intracellular Ca2+ level that mainly determines APD heart rate adaptation. The inhibition of 
IK1 causes membrane depolarization which may lead to changes in the function of the sodium- 
calcium exchanger (NCX) promoting increase in intracellular calcium levels. Further studies 
are needed to find out whether the combined block of different potassium currents affect the 
APD heart rate adaptation and whether decreased adaptation correlates with prolonged short-
term QT variability. 
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Our results also show that QT heart rate adaptation is a manifestation of cellular APD 
heart rate adaptation. Furthermore, ICa,L inactivation and IKs activation kinetics determine the 
fast phase of HR adaptation while INaK and [Na+]i dynamics are key in the slow and final 
phase. Regarding the ICa,L inhibition, computer simulation and experiments carried out on 
canine right ventricular papillary muscle provided controversial results: simulation showed 
the increase of τfast values while decreased τfast values were experienced in dog papillary 
muscle associated with faster APD adaptation to heart rate changes. Our experimental results 
are confirmed by another study where the low incidence of afterdepolarization following 
administration of amiodarone was related to the ability of the drug to slow ICa,L and decrease 
τfast (Wegener et al, 2006). Furthermore, clinical observations also suggest that patients who 
benefit from amiodarone therapy, the loss of pro-arrhythmia has been explained by the 
accelerated adaptation of QT interval to heart rate changes (Smetana et al., 2004). Our 
experimental results and computer simulation study equally indicate the crucial role of IKs in 
the fast phase of APD adaptation as previously suggested. (Carmeliet 2006; Eisner et al., 
2009; Faber et al, 2000) 90 % inhibition of the IKs current during simulation resulted in a 71–
82/63–76% reduction in τfast following acceleration/deceleration in human (Pueyo et al., 
2010), while increase were observed in dog ventricular preparations under the effect of 0.25 
µM HMR 1556 (~ full block). Alterations in the IKs current, as showed in experiments and 
simulation, may be associated with reduced APD HR adaptation causing ventricular 
arrhythmias. Clinical observations also confirmed the major role of IKs in arrhythmogenesis: 
gain of function mutations in the KCNQ1 gene with reduced time constant of IKs activation 
gate, causes short QT syndrome associated with high incidence of sudden cardiac death. 
(Béllocq et al., 2004) Computer simulations and experiments were in good agreement 
regarding the inhibition of INaK. Both our experimental and simulation results show the key 
role of INaK in the slow phase of APD adaptation. Large τslow values are also associated with 
flat APD restitution slopes, which could favor the stability of reentrant circuits and thus could 
increase arrhythmic risk (Pueyo et al, 2010). Simulations in human and dog also suggest that 
DADs develop under ~ 60 % INaK inhibition, the degree of block associated with ischemic 
heart disease and patient with heart failure treated with digitalis (Pueyo et al., 2010; 
Bundgaard et al., 1996). Alterations in these mechanisms of transmembrane ionic transport 
result in protracted APD heart rate adaptation and increased risk of arrhythmias mostly due to 
increased risk of afterdepolarization development. Thus, our results suggest that slow QT rate 
adaptation, as measured in surface ECG of patients at high arrhythmic risk, is a reflection of 
adverse ionic changes, which, upon further deterioration, may facilitate arrhythmia initiation. 
  
49 
6. Conclusions 
 
6.1 Conclusions: studies on repolarization reserve 
In conclusion, both rabbits and dogs are susceptible to pharmacological impairment of 
repolarization reserve and concomitant ventricular arrhythmia induction by compounds that 
inhibit repolarizing currents. Our results have further confirmed that STVQT may be a better 
predictor of drug-induced TdP development than conventional ECG parameters characterizing 
repolarization prolongation. Importantly, however, rabbits are more susceptible to combined 
inhibition of IK1+IKr than dogs, and dogs are more susceptible to combined inhibition of 
IK1+IKs than  rabbits, suggesting different relative roles of IK1 and IKs in repolarization reserve 
in the two species. These results warrant cautious evaluation of the potential pro-arrhythmic 
adverse effects and cardiovascular safety of candidate compounds in rabbit and dog models. 
The different relative roles of repolarizing potassium currents in dogs and rabbits need to be 
considered when extrapolating animal experimental pro-arrhythmia study results to human 
clinical situations. In addition, our results also strongly suggest that the IK1 current plays an 
important role in repolarization reserve. The underlying mechanism of arrhythmia generation 
following impairment of repolarization reserve by inhibition of IK1 seems to be increased 
ectopic firing rather than the development of EADs. 
 
6.2 Conclusions: repolarization adaptation to abrupt heart rate changes 
Our experiments strongly suggest (also confirmed by computer simulations) that ICa,L 
and IKs currents determine the fast phase of heart rate adaptation while INaK dynamics are 
critical in the slow and final phase. The results also demonstrate that INaK inhibition, as it 
occurs in myocardial ischemia and heart failure patients, results in decreased APD adaptation, 
and might be a pro-arrhythmic risk factor. Large tslow due to INaK inhibition is associated with 
an increase in action potential triangulation and may promote ICa,L reactivation, resulting in an 
increased risk of delayed afterdepolarization formation. Different outcomes were observed in 
the case of IKs and ICa,L. Experiments demonstrate that reduced IKs is associated with delayed 
APD adaptation in the fast phase while ICa,L block correlated with increased fast phase APD 
adaptation kinetics. It should be noted that experimental results following ICa,L block were in 
conflict with computer modeling results, highlighting some existing imperfections in the 
human action potential computer model. Interestingly, IKr inhibition had no effect on APD 
heart rate adaptation kinetics and these results were in agreement with computer simulation 
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studies. These results provide new insights into the mechanisms of ventricular rate adaptation 
and its connection to pro-arrhythmic risk. 
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Abstract 
The reliable assessment of the pro-arrhythmic potential of drugs in development remains 
elusive. Rabbits and dogs are commonly used in pro-arrhythmia models. Species differences 
in repolarizing potassium currents are poorly understood. We investigated the incidence of 
drug-induced Torsades de Pointes, measured conventional ECG parameters and the short-term 
variability of the QT interval (STVQT) following combined pharmacological inhibition of IK1 
+ IKs and IK1 + IKr in conscious dogs and anesthetized rabbits. A high TdP incidence was 
observed following inhibition of IK1 + IKs in dogs (67% vs 14% in rabbits). Rabbits exhibited 
higher TdP incidence after IK1 + IKr inhibition (72% vs 14% in dogs). Increased TdP incidence 
was associated with significantly larger STVQT in both models. The different relative roles of 
IK1 and IKs in dog and rabbit repolarization reserve should be taken into account when 
extrapolating the results of animal pro-arrhythmia models to humans. A stronger 
repolarization reserve in dogs (likely due to stronger IK1 and IKs) and a more human-like 
arrhythmia susceptibility of rabbits argues for the preferred use of rabbit in the evaluation of 
pro-arrhythmic adverse effects. 
 
Key words 
Repolarization, repolarization reserve, electrophysiology, potassium channels, Torsades de 
Pointes, IK1, IKs, IKr 
 3 
Introduction 
The proper assessment of the pro-arrhythmic potential of candidate compounds is a major 
concern for drug development (Haverkamp et al. 2000), since drug-induced arrhythmias, 
including Torsades de Pointes (TdP), can lead to sudden cardiac death (Fenichel et al. 2004). 
The prediction of TdP in clinical setting is very difficult since the incidence of drug-induced 
TdP is very low (1:100 000), however, drug associated sudden cardiac deaths have led to the 
withdrawal of several compounds in the past. Therefore, the reliable preclinical assessment of 
pro-arrhythmic side effects is essential. Importantly, current methods mostly concentrate on 
testing the hERG blocking and/or ventricular repolarization prolonging effects of these 
compounds mostly in healthy tissues and animals, and these cardiac safety tests are not 
sensitive enough (International Conference on Harmonisation, guidance E14 2005; 
International Conference on Harmonisation, guidance S7B 2005; Thomsen et al. 2006; Farkas 
and Nattel 2010). 
The inhibition of cardiac potassium channels prolongs repolarization and refractoriness, 
leading to Class III antiarrhythmic effects (Sing and Vaughan-Williams 1970). However, 
excessive repolarization prolongation by Class III antiarrhythmic drugs, seen as marked QT 
interval prolongation on the ECG, can result in drug-induced TdP (Hondeghem and Snyders 
1990; El-Sherif 1992). On the other hand, experimental and clinical studies suggest that the 
degree of repolarization prolongation does not show a close correlation with subsequent 
ventricular arrhythmia development (van Opstal et al. 2001; Thomsen et al. 2004; Lengyel et 
al. 2007; Hinterseer et al. 2009; Hinterseer et al. 2010). In these cases, without marked 
prolongation of the QT interval, repolarization reserve may be reduced with a consequent 
increase in arrhythmia susceptibility. According to the concept of repolarization reserve, 
normal cardiac repolarization is controlled by different potassium currents in a redundant 
way, and congenital or acquired (e.g. mild potassium current inhibition by a non-
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cardiovascular drug) decrease in the function of a single repolarizing current does not always 
lead to marked repolarization prolongation, since other currents can compensate for the lost 
function (Roden 1998; Varró and Baczkó 2011). In the case of reduced repolarization reserve, 
additional inhibition of another repolarizing current can result in excessive prolongation of 
repolarization and can provoke serious ventricular arrhythmias. 
Experimental evidence from studies on both animal and human ventricular myocardium 
point to a critically important role for the slow component of the delayed rectifier potassium 
current (IKs) in ventricular repolarization reserve (Volders et al. 1999; Varró et al. 2000; 
Lengyel et al. 2001; Volders et al. 2003; Jost et al. 2005; Abi-Gerges et al. 2006; Lengyel et 
al. 2007). In addition to IKs, however, other ventricular repolarizing potassium currents may 
significantly contribute to repolarization reserve, including Ito (Virág et al. 2011) and IK1 
(Biliczki et al. 2002). There is considerable variation in the expression of key repolarizing 
potassium channels in different mammalian species (Zicha et al. 2003.). The dog and rabbit 
are frequently used species in various in vitro and in vivo pro-arrhythmia models. Therefore, it 
is reasonable to assume that species specific ion channel expression profiles may result in 
species dependent alterations in responses to potassium channel blockers (Nerbonne and Kass 
2005). Such differences may significantly influence the value of data obtained in these models 
for human extrapolation. Indeed, a very recent study found similar IKr densities and 
significantly lower IK1 and IKs densities in human ventricular myocytes compared to their 
canine counterparts, suggesting that humans may exhibit a reduced repolarization reserve and 
might be more susceptible to the pro-arrhythmic adverse effects of IKr blocking drugs (Jost et 
al. 2013). It is not clear, however, how species specific potassium channel expressions 
translate into differences in arrhythmia development in dogs and rabbits. We have shown 
previously that repolarization reserve impairment by pharmacological block of IKs increased 
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arrhythmia susceptibility during subsequent IKr inhibition in dogs and rabbits in a similar 
degree (Lengyel et al. 2007). 
In the present study, we studied the effects of combined pharmacological inhibition of IK1 
and IKs, as well as IK1 and IKr on ECG parameters and the incidence of TdP in conscious dogs 
and anesthetized rabbits. We also investigated whether TdP development was paralleled by 
increased short-term variability of the QT interval, a novel ECG parameter suggested for 
more reliable prediction of drug-induced ventricular arrhythmias. 
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Materials and methods 
Ethical issues 
All experiments were carried out in compliance with the Guide for the Care and Use 
of Laboratory Animals (U.S.A. NIH publication No 85-23, revised 1996) and the protocol had 
been approved by the Ethical Committee for the Protection of Animals in Research of the 
University of Szeged, Szeged, Hungary (approval number I-74-5-2012); and by the 
Department of Animal Health and Food Control of the Ministry of Agriculture (authority 
approval number XIII/1211/2012). 
 
Conscious dogs 
Beagle dogs of either sex weighing 10-15 kg were used for the experiments. The 
animals were allowed to accomodate to experimental personnel and equipment, every day for 
a week before the start of the actual studies. After a 20 min equilibration period, baseline 
recordings were obtained. The animals were then randomly assigned to the following groups: 
the first group of dogs (n=7) were first administered the IK1 inhibitor BaCl2 (3 mg/kg) 
followed by the IKr inhibitor dofetilide (25 µg/kg) intravenously after a 20 min equilibration 
period and in the second group (n=6) the animals received the IKs inhibitor HMR 1556 (1 
mg/kg) first followed by the IK1 inhibitor BaCl2 (3 mg/kg) intravenously after a 20 min 
equilibration period. The drugs were administered during a 5 min continuous i.v. infusion 
(Terufusion TE-3, Terumo Europe, Leuven, Belgium). The electrocardiogram was obtained 
using precordial leads and was digitized and stored on a computer for later analysis using 
National Instruments data acquisition hardware (National Instruments, Austin, TX, USA) and 
SPEL Advanced Haemosys software (v3.2, Experimetria Ltd., Budapest, Hungary; MDE 
Heidelberg GMBH, Heidelberg, Germany). The PQ, RR, QT intervals were measured as the 
average of 30 consecutive beats (the minimum number of beats required for the calculation of 
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beat-to-beat short-term variability of an interval, see below) and the frequency corrected QT 
interval (QTc) was calculated using a formula recommended specifically for Beagle dogs: 
QTc = QT – (0,087 * (RR-1000)) (Tattersall et al. 2006; Van de Water et al. 1989). The 
intervals were measured at the following time points during the experiments: (i) 2 min before 
the start of drug infusion (baseline); (ii) 5 min after the end of drug infusions and (iii) the 
ECG section directly preceding the arrhythmia still in sinus rhythm if TdP (Figure 1) or other 
ventricular arrhythmias occurred. 
 
Anesthetized rabbits 
Male New Zealand white rabbits (2-3 kg) were anesthetized with thiopentone (50 
mg/kg i.v.) given into the marginal vein of the right ear. A catheter filled with isotonic saline 
containing 500 IU/mL heparin was inserted into the left carotid artery for the measurement of 
arterial blood pressure. The right jugular vein was cannulated for subsequent i.v. drug 
administration. The animals were allowed to stabilize for 20 min and baseline measurements 
were taken. The first group (n=7) was administered the IK1 inhibitor BaCl2 (0.3 mg/kg, in a 
volume of 2 ml/kg during a 5 min infusion) followed by the IKr inhibitor dofetilide (25 µg/kg), 
20 min after BaCl2 administration. The second group (n=7) received the IKs inhibitor HMR 
1556 (0.1 mg/kg) followed by the IK1 inhibitor BaCl2 (0.3 mg/kg) intravenously 20 min after 
HMR 1556 administration. 
The blood pressure and the electrocardiogram (leads I, II and III) were continuously 
recorded (at 200 Hz), digitized and stored on a computer for analysis using National 
Instruments data acquisition hardware (National Instruments, Austin, TX, USA) and SPEL 
Advanced Haemosys software (v3.2, Experimetria Ltd., Budapest, Hungary; MDE Heidelberg 
GMBH, Heidelberg, Germany). The PQ, RR, QT intervals were measured as the average of 
30 beats (the minimum number of beats required for the calculation of short-term variability 
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of an interval, see below). During the measurement of the QT interval in anaesthetized 
rabbits, the guidelines described by Farkas et al. (2004) were followed. In rabbits with a 
significantly faster heart rate than that of humans, QTc calculated with Bazett’s formula does 
not accurately reflect the heart rate dependent changes in QT interval. Accordingly, QTc was 
calculated by a formula specifically suggested for anaesthetized rabbits by Batey and Coker 
(2002) as follows: QTc = QT – (0.704 * (RR-250)). 
 
Short-term beat-to-beat variability of the RR (STVRR) and QT intervals (STVQT) 
Temporal instability of beat-to-beat heart rate and repolarization can be quantitatively 
characterized by the calculation of the beat-to-beat short-term variability (STV) of RR or QT 
intervals, respectively. The calculation of STV is based on previous detailed mathematical 
analysis (Brennan et al. 2001), and was calculated as follows: STV = ∑|Dn+1-Dn| (30x√2)-1, 
where D is the duration of the QT or RR interval. The intervals used in the calculation were 
the result of 30 consecutive interval measurements in sinus rhythm at a given time point 
during the experiments. In the case of experiments where TdP occurred, the measurements 
were taken in sinus rhythm prior to the development of TdP. To illustrate temporal instability 
of the QT interval, Poincaré plots of the QT intervals were constructed where each QT value 
was plotted against its former value (Figures 3 and 5, panel B). The STV represents the 
mean orthogonal distance to the line-of-identity on the Poincaré plot. 
 
Compounds 
HMR 1556 (Aventis Pharma, Frankfurt am Main, Germany) was dissolved in 
dimethylsulfoxide (DMSO, 0.1%) as a stock solution of 10 µM. Dofetilide (Gedeon Richter 
Ltd., Budapest, Hungary) was dissolved in saline as a stock solution of 5 µM. BaCl2 was 
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dissolved in distilled water as a stock solution of 100 mM. Each stock solution was diluted 
immediately before use. 
 
Statistical analysis 
The incidence of TdP (%) was compared by using the χ2 test with Yates’ correction. 
All other data are expressed as means + SD. Data within groups were compared after analysis 
of variance (repeated measures one-way ANOVA) by Bonferroni’s post test and the groups 
were compared in pairs by means of Student’s “t” test. A level of p<0.05 was considered to be 
statistically significant. 
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Results 
Effect of combined IK1 and IKr inhibition on RR and QTc intervals in conscious dogs and 
anesthetized rabbits 
Both in dogs and rabbits, the administration of the IK1 inhibitor BaCl2 alone did not 
change heart rate and the RR intervals (Figure 2A). However, infusion of the IKr inhibitor 
dofetilide significantly increased RR intervals (Figure 2A) and decreased heart rate (dogs: 
66.9±16.96 vs. 80.5±12.12 beats/min in control; rabbits: 213.9±1.92 vs. 258.6±1.26 beats/min 
in control, p<0.05) in both species. In our previous study, the IKr inhibitor dofetilide 
administered alone did not alter the RR interval but as expected, significantly prolonged the 
QTc interval in conscious dogs and anesthetized rabbits (Lengyel et al. 2007). 
In conscious dogs, IK1 inhibition significantly prolonged the frequency corrected QT 
interval, calculated with the Van de Water formula (Van de Water et al., 1989), and dofetilide 
infusion caused a further, significant prolongation of the QTc interval (Figure 3A left panel). 
The uncorrected QT intervals yielded similar prolongation: 317.4±47.9 ms after IK1 block and 
373.5±37.8 ms after combined IK1+IKr inhibition vs. 221.4±11.7 ms in controls, (p<0.05). In 
anesthetized rabbits, only the combination of IK1 and IKr inhibition resulted in significant QTc 
interval prolongation (Figure 3A right panel). Again, the uncorrected QT intervals showed a 
similar prolongation only after combined IK1+IKr inhibition (150.6±5.88 ms after IK1 inhibition 
and 167.8±6.27 ms after BaCl2 and dofetilide combination vs. 147.2±5.46 ms in control). 
 
Effect of combined IK1 and IKr inhibition on the short-term variability of RR (STVRR) 
and QT intervals (STVQT) in conscious dogs and anesthetized rabbits 
Since heart rate affects repolarization duration, the short-term variability of the RR 
intervals were also calculated in addition to STVQT, the ECG parameter recently suggested for 
more reliable prediction of ventricular arrhythmias. In conscious dogs, STVRR did not change 
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significantly following IK1 and combined IK1+IKr inhibition (Figure 2B left panel). In 
anesthetized rabbits, the combination of BaCl2 and dofetilide slightly, but significantly 
increased STVRR, however, the magnitude of these changes (less than 0.5 ms) makes it very 
unlikely that this STVRR change markedly influenced repolarization variability (Figure 2B 
right panel). The IKr inhibitor dofetilide administered alone did not alter STVRR in conscious 
dogs and anesthetized rabbits in our previous study (Lengyel et al. 2007). 
 The Poincaré plots on Figure 3B illustrate repolarization temporal instability in two 
individual animals, a conscious dog (left panel) and an anesthetized rabbit (right panel) 
following IK1 and combined IK1+IKr inhibition. Both animals exhibited TdP arrhythmia as a 
result of BaCl2 and dofetilide combination, and the scatter of data points covering a large area 
on the plot following this combination represents large STVQT values in these animals (15.8 
ms in the dog and 4.9 ms in the rabbit). Grouped STVQT data showed a significant increase in 
both species following combined IK1+IKr inhibition (Figure 3C). Dofetilide alone did not 
increase STVQT in conscious dogs, however, it significantly increased STVQT in anesthetized 
rabbits in our previous study (Lengyel et al. 2007). 
 
Effect of combined IKs and IK1 block on RR and QTc intervals in conscious dogs and 
anesthetized rabbits 
The IKs inhibitor HMR 1556 did not change the RR interval significantly in conscious 
dogs or anesthetized rabbits, and this result was in good agreement with our previous 
observations (Lengyel et al., 2007). The combined inhibition of IKs+IK1, however, caused a 
significant increase in RR intervals and decrease in heart rate in rabbits only (Figure 4A right 
panel). 
In conscious dogs, IKs inhibition significantly increased the frequency corrected QT 
interval, similarly to our previous observations in conscious dogs (Lengyel et al., 2007). In 
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these animals, subsequent infusion of BaCl2 caused a further, significant QTc prolongation 
(Figure 5A left panel). The uncorrected QT intervals showed similar prolongation: 
317.5±35.2 ms after IKs block and 387.4±45.4 ms after combined IKs+IK1 inhibition vs. 
230.5±7.6 ms in controls, (p<0.05). In anesthetized rabbits, IKs inhibition did not alter QTc, 
and combined IKs+IK1 inhibition only had a slight tendency to increase QTc but this change 
did not prove to be statistically significant (Figure 5A right panel).  
 
Effect of combined IKs and IK1 inhibition on the short-term variability of RR (STVRR) 
and QT (STVQT) intervals in conscious dogs and anesthetized rabbits 
HMR 1556 did not alter STVRR in conscious dogs or anesthetized rabbits. The 
combined inhibition of IKs+IK1 caused a significant, but again, very small (less than 1 ms) 
increase in STVRR in anesthetized rabbits (Figure 4B right panel).  
The Poincaré plots on Figure 5B illustrate repolarization temporal instability in two 
individual animals, a conscious dog (left panel) and an anesthetized rabbit (right panel) 
following IKs and combined IKs+IK1 inhibition. The shift of QT interval data points to the right 
and upward direction in the conscious dog represent the above described QT prolongation 
following HMR 1556 administration. Careful observation of the plot reveals that in this 
animal, that later developed TdP after combined IKs+IK1 inhibition, the QT variability only 
increased after HMR 1556 and BaCl2 combination (Figure 5B left panel). In accordance with 
grouped STVQT data represented on Figure 5C (right panel), in the representative rabbit on 
Figure 5B STVQT did not increase significantly after HMR 1556 or HMR 1556+BaCl2 
combination in anesthetized rabbits. In contrast, in conscious dogs this combination led to a 
significant increase in STVQT (Figure 2E left panel). Importantly, in parallel to this STVQT 
increase, conscious dogs responded to combined IKs+IK1 inhibition with significantly 
 13 
increased TdP incidence, while only one of 7 rabbits developed TdP following this 
combination, and the rabbit grouped data did not show elevated STVQT (Figure 5C). 
 
Effect of combinations of IK1 and IKr inhibition, and IKs and IK1 inhibition on the 
incidence of TdP in conscious dogs and anesthetized rabbits 
As shown on Figure 6A and 6B, inhibition of IK1 or IKs alone did not provoke TdP in 
any of the animals. We have shown previously that the IKr inhibitor dofetilide alone did not 
cause TdP in conscious dogs and caused TdP in 25% of anesthetized rabbits (Lengyel et al., 
2007). Combined inhibition of repolarizing currents, however, led to a significant amount of 
TdP episodes in both species, albeit in a different manner. 
Interestingly, conscious dogs and anesthetized rabbits exhibited different TdP 
incidence following the combined inhibition of key potassium currents: a significant amount 
of conscious dogs developed TdP following IKs+IK1 inhibition, while only one rabbit 
developed TdP after this combination. On the other hand, TdP incidence increased 
significantly following IK1+IKr inhibition in rabbits, while only one dog exhibited TdP 
following BaCl2+dofetilide administration (Figures 6A and 6B). 
 
Discussion 
Dogs and rabbits are frequently used species for pro-arrhythmia studies, and we 
previously established a pro-arrhythmia model based on repolarization reserve impairment 
achieved by pharmacological inhibition of IKs, a key potassium current in repolarization 
reserve (Lengyel et al., 2007). Recently, other potassium channels were also implicated in 
repolarization reserve, including IK1 (for a recent review see Varró and Baczkó, 2011). 
Species differences exist in the expression of important ion channels carrying repolarizing 
current (Zicha et al. 2003), most likely leading to species-specific differences in repolarization 
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reserve and in responses to compounds with even mild potassium channel inhibitory 
properties (Nerbonne and Kass 2005). Therefore, further characterization of the roles different 
potassium currents play in canine and rabbit pro-arrhythmia models are needed to assist in the 
proper extrapolation of data obtained in these models to human subjects. 
 In the present study we investigated the effects of repolarization reserve impairment 
by pharmacological inhibition of IK1 in combination with IKs and IKr on the incidence of the 
typical drug-induced arrhythmia, TdP, and different ECG parameters, in a similar 
experimental setup to our previous study where the effects of the combined pharmacological 
inhibition of IKs and IKr were characterized in conscious dogs and anesthetized rabbits 
(Lengyel et al., 2007). Here we show that combined pharmacological inhibition of other 
potassium currents leads to repolarization reserve impairment and high incidence of TdP in 
conscious dogs and anesthetized rabbits. However, dogs and rabbits exhibited markedly 
different patterns of TdP development in response to combined IK1+IKr and IKs+IK1 inhibition 
suggesting that at least some of these currents may play different relative roles in 
repolarization reserve in the two species. In contrast, we previously showed that both species 
responded with a high incidence of TdP paralleled by significant increases of short-term 
variability of the QT interval, irrespective of the sequence of IKs and IKr inhibitor 
administration (Lengyel et al., 2007). 
The key role of IKs in ventricular repolarization reserve is well established in different 
animal species as well as in humans (Volders et al. 1999; Varró et al. 2000; Lengyel et al. 
2001; Volders et al. 2003; Jost et al. 2005; Abi-Gerges et al. 2006; Lengyel et al. 2007; Jost et 
al., 2007; Johnson et al., 2010). However, a recent study highlighted that due to lower IKs 
densities in human hearts, repolarization reserve may be reduced in humans compared to dogs 
(Jost et al., 2013). Attributed to low-level IKs beta-subunit minK expression, a small IKs and 
increased TdP susceptibility were described in rabbits (Lu et al., 2001; Zicha et al., 2003). In a 
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recent comparative study, the kinetics of rabbit IKs have been found more human-like 
compared to IKs in guinea-pigs and dogs (Jost et al., 2013b). These data indicate that despite 
the relatively well characterized role of IKs in repolarization reserve, the significant 
differences described in IKs subunit expression, current densities and kinetics in rabbits and 
dogs make human extrapolation of results somewhat difficult. 
The roles other repolarizing potassium currents may play in repolarization reserve are 
poorly understood. Among these repolarizing potassium currents, possible roles for Ito (Virag 
et al., 2011) and IK1 (Biliczki et al., 2002; Varró and Baczkó, 2011) in repolarization reserve 
have been suggested. In LQT7 (Andersen-Tawil syndrome), loss of function mutations in 
Kir2.1 channels may significantly decrease IK1 current, however, the substantially increased 
pro-arrhythmic risk in these patients is not accompanied by marked QTc prolongation on the 
ECG (Zhang et al., 2005). Computer modelling studies also support a key role for IK1 in 
ventricles: in these models, reduction of IK1 in addition to IKr block led to early 
afterdepolarizations (Ishihara et al., 2009). A variety of channel subtypes can be responsible 
for the IK1 current, including alpha-subunits Kir2.1, Kir2.2, Kir2.3, Kir2.4 (for a recent review 
see Anumonwo and Lopatin, 2010). Significant species-specific differences in the expression 
of Kir2.x proteins have been reported previously (Wang et al., 1998; Melnyk et al., 2002; 
Dhamoon and Jalife, 2005). Different heteromeric assembly of Kir2.x proteins leads to 
different IK1 characteristics (Dhamoon et al., 2004) and most likely, to altered overall cardiac 
electrophysiological responses to drugs. In rabbit cardiomyocytes, a heteromeric assembly of 
Kir2.1 and Kir2.2 was reported (Zobel et al., 2003). In dogs, Kir2.2 and Kir2.4 levels were 
minimal, while in humans, Kir2.3 mRNA expression was on a similar level to Kir2.1 and 
Kir2.1 mRNA expression was three times higher in dogs compared to human (Jost et al., 
2013). 
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 Based on these studies and also supported by the present study, due to stronger IK1 and 
IKs in dogs compared to rabbits and humans, dogs may exhibit larger repolarization reserve 
compared to the other two species. Therefore, rabbit pro-arrhythmia models based on 
pharmacologically impaired repolarization reserve may represent greater arrhythmia 
susceptibility and may be more useful than canine models in predicting human 
electrophysiological responses to drugs affecting cardiac ventricular repolarization. 
In this study, the short-term variability of the QT interval was calculated in order to 
assess temporal instability of repolarization following pharmacological inhibition of 
repolarizing potassium currents. The STVQT characterizes differences in the QT intervals of 
consecutive heart beats and has been suggested as a more reliable measure of pro-arrhythmic 
risk associated with impaired repolarization reserve compared to conventional ECG 
parameters of repolarization (Berger at al 2003; Varkevisser et al 2012). In this regard, a 
number of previous in vivo and in vitro animal experimental and clinical studies (van Opstal 
et al., 2001; Thomsen et al., 2004; Lengyel et al 2007; Hinterseer et al., 2009; Hinterseer et 
al., 2010) found that STVQT was increased and showed a better correlation with subsequent 
arrhythmias than QT prolongation in animals or individuals with decreased repolarization 
reserve later exhibiting serious ventricular arrhythmias. We found in this study that combined 
inhibition of IK1+IKr and IKs+IK1 led to increased STVQT in parallel with increased incidence of 
TdP in most cases, further supporting the role of STVQT determination in ventricular 
arrhythmia risk estimation. It should be noted that in dogs, following IK1+IKr inhibition a 
significant increase in STVQT was found with only one animal showing TdP, however, very 
short episodes of nonsustained monomorphic ventricular tachycardia were observed in three 
additional animals. 
In conclusion, both rabbits and dogs are susceptible to pharmacological impairment of 
repolarization reserve and concomitant ventricular arrhythmia induction by compounds that 
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inhibit repolarizing currents. This study has further confirmed that STVQT may be a better 
predictor of subsequent drug-induced TdP development than conventional ECG parameters 
characterizing repolarization prolongation. Importantly, however, rabbits are more susceptible 
to combined inhibition of IK1+IKr than dogs, and dogs are more susceptible to combined 
inhibition of IK1+IKs than rabbits, suggesting different relative roles of IK1 and IKs in 
repolarization reserve in these species. These results warrant cautious evaluation of the 
potential proarrhythmic adverse effects and cardiovascular safety of candidate compounds in 
rabbit and dog models. The different relative roles of repolarizing potassium currents in these 
species need to be considered when extrapolating rabbit and canine proarrhythmia study 
results to humans.    
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Figure legends 
 
Figure 1. Representative Torsades de Pointes (TdP) recording from (A) conscious dog 
following combined inhibition of IKs + IK1 and from (B) an anesthetized rabbit following the 
combined inhibition of IK1+IKr. 
 
Figure 2. Effect of IK1 inhibition (i.v. BaCl2) and combined IK1+IKr (i.v. BaCl2+dofetilide) 
inhibition on (A) RR interval and (B) short-term variability of the RR interval (STVRR) in 
conscious dogs and anesthetized rabbits. N=7 dogs and 7 rabbits/group; *p<0.05 vs. control 
values; #p<0.05 vs. IK1 inhibition. 
 
Figure 3. Effect of IK1 inhibition (i.v. BaCl2) and combined IK1+IKr (i.v. BaCl2+dofetilide) 
inhibition on (A) frequency corrected QT interval (QTc); (B and C) short-term variability of 
the QT interval (STVQT) in conscious dogs and anesthetized rabbits. For details on Poincaré 
plot (B) description see text. N=7 dogs and 7 rabbits/group; *p<0.05 vs. control values; 
#p<0.05 vs. IK1 inhibition. 
 
Figure 4. Effect of IKs inhibition (i.v. HMR 1556) and combined IKs+IK1 (i.v. HMR 
1556+BaCl2) inhibition on (A) RR interval and (B) short-term variability of the RR interval 
(STVRR) in conscious dogs and anesthetized rabbits. N=6 dogs and 7 rabbits/group; *p<0.05 
vs. control values; #p<0.05 vs. IKs inhibition. 
 
Figure 5. Effect of IKs inhibition (i.v. HMR 1556) and combined IKs+IK1 (i.v. HMR 
1556+BaCl2) inhibition on (A) frequency corrected QT interval (QTc); (B and C) short-term 
variability of the QT interval (STVQT) in conscious dogs and anesthetized rabbits. For details 
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on Poincaré plot (B) description see text. N=6 dogs and 7 rabbits/group; *p<0.05 vs. control 
values; #p<0.05 vs. IKs inhibition. 
 
Figure 6. Effect of (A) IK1 inhibition (i.v. BaCl2) and combined IK1+IKr (i.v. BaCl2+dofetilide) 
inhibition and (B) IKs inhibition (i.v. HMR 1556) and combined IKs+IK1 (i.v. HMR 
1556+BaCl2) inhibition on incidence of Torsades de Pointes (TdP) chaotic ventricular 
arrhythmia in conscious dogs (left panels) and anesthetized rabbits (right panels). N=7 and 6 
dogs, and 7 rabbits/group; *p<0.05 vs. control values. 
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Figure 1. Representative Torsades de Pointes (TdP) recording from (A) conscious dog following 
combined inhibition of IKs + IK1 and from (B) an anesthetized rabbit following the combined inhibition 
of IK1+IKr. 
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Figure 2. Effect of IK1 inhibition (i.v. BaCl2) and combined IK1+IKr (i.v. BaCl2+dofetilide) inhibition 
on (A) RR interval and (B) short-term variability of the RR interval (STVRR) in conscious dogs and 
anesthetized rabbits. N=7 dogs and 7 rabbits/group; *p<0.05 vs. control values; #p<0.05 vs. IK1 
inhibition. 
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Figure 3. Effect of IK1 inhibition (i.v. BaCl2) and combined IK1+IKr (i.v. BaCl2+dofetilide) inhibition 
on (A) frequency corrected QT interval (QTc); (B and C) short-term variability of the QT interval 
(STVQT) in conscious dogs and anesthetized rabbits. For details on Poincaré plot (B) description see 
text. N=7 dogs and 7 rabbits/group; *p<0.05 vs. control values; #p<0.05 vs. IK1 inhibition. 
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Figure 4. Effect of IKs inhibition (i.v. HMR 1556) and combined IKs+IK1 (i.v. HMR 1556+BaCl2) 
inhibition on (A) RR interval and (B) short-term variability of the RR interval (STVRR) in conscious 
dogs and anesthetized rabbits. N=6 dogs and 7 rabbits/group; *p<0.05 vs. control values; #p<0.05 vs. 
IKs inhibition. 
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Figure 5. Effect of IKs inhibition (i.v. HMR 1556) and combined IKs+IK1 (i.v. HMR 1556+BaCl2) 
inhibition on (A) frequency corrected QT interval (QTc); (B and C) short-term variability of the QT 
interval (STVQT) in conscious dogs and anesthetized rabbits. For details on Poincaré plot (B) 
description see text. N=6 dogs and 7 rabbits/group; *p<0.05 vs. control values; #p<0.05 vs. IKs 
inhibition. 
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Figure 6. Effect of (A) IK1 inhibition (i.v. BaCl2) and combined IK1+IKr (i.v. BaCl2+dofetilide) 
inhibition and (B) IKs inhibition (i.v. HMR 1556) and combined IKs+IK1 (i.v. HMR 1556+BaCl2) 
inhibition on incidence of Torsades de Pointes (TdP) chaotic ventricular arrhythmia in conscious dogs 
(left panels) and anesthetized rabbits (right panels). N=7 and 6 dogs, and 7 rabbits/group; *p<0.05 vs. 
control values. 
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